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Abstract

TIME COURSE OF VASCULAR FUNCTION CHANGES FOLLOWING AN ACUTE
MAXIMAL EXERCISE BOUT IN OBESE AND NORMAL WEIGHT MALES
By R. Lee Franco, Ph.D.
A dissertation submitted in partial fulfillment of the requirements for the degree of Doctor
of Philosophy at Virginia Commonwealth University.
Virginia Commonwealth University, 2009
Director: Ronald K. Evans, Ph.D.
Associate Professor, Department of Health and Human Performance

One of the earliest sub-clinical stages associated with atherosclerosis is endothelial
dysfunction (ED), which has been shown to predict future cardiovascular events. Chronic
exercise is thought to improve endothelium-dependent vasodilation; however, few studies
have evaluated the effects of acute exercise on vascular function (VF). Moreover, studies
evaluating ED following an exercise training program lack a standardized time frame in
which to measure VF. Although most studies require subjects to abstain from exercise for
24 hours prior to any VF measure, no study to date has assessed VF longer than 24 hours
after the cessation of exercise. Additionally, no studies have compared VF responses in
vii

obese and non-obese individuals following acute exercise. Purpose: Therefore, the
purpose of this study was to evaluate VF, as determined by the assessment of forearm
blood flow (FBF) and vascular reactivity (VR) before and up to 48 hours after a single
bout of maximal exercise in obese and non-obese males. Methods: Twelve obese (37.0 ±
1.1 kg/m2) and twelve non-obese (21.9 ± 0.3 kg/m2) males volunteered to participate. FBF
was assessed before and during reactive hyperemia (RH). FBF measures were obtained
prior to (PRE-E), immediately after (POST-E), and at 1 (POST-1), 2 (POST-2), 24 (POST24), and 48 (POST-48) hours after exercise. Total excess flow, calculated as the difference
between baseline FBF and FBF during RH, was used as an indicator of VR. Blood
samples were also obtained at each time point to evaluate the response of interleukin-6 (IL6) and tumor necrosis factor alpha (TNF-α), which are potential modifiers of VF. Results:
Baseline FBF and FBF during RH were significantly (P < 0.05) increased in both groups
POST-E before returning to baseline values by POST-1. VR was enhanced in both groups
POST-E, although the magnitude of change was greater in non-obese males. VR was
significantly (P < 0.05) increased in non-obese males POST-E and was not significantly (P
< 0.05) reduced until POST-48. Concentrations of IL-6 and TNF-α were unchanged in
response to exercise in non-obese and obese males. Conclusions: An acute bout of
maximal exercise significantly increased forearm endothelium-dependent vasodilation in
non-obese and obese males. Additionally, an increased reactive vasodilation was observed
only in non-obese males following exercise. These results also suggest that in non-obese
males, measurements used to verify improvements in VF following exercise training
should be employed after a minimum of 48 hours following physical activity.
viii

Introduction

Atherosclerotic cardiovascular disease (CVD) is the leading cause of death in the
United States, and has a 50% prevalence risk after the age of 40 years. (Lloyd-Jones et al.,
2004). Atherosclerosis is distinguished by increased thickening of the arterial wall,
accounting for approximately three-fourths of all CVD deaths (Rosamond et al., 2007).
The clinical signs of CVD are final expressions of a disease process that has been
progressing for decades. One of the earliest sub-clinical stages in the atherosclerotic
process is impairment of endothelium-dependent vasodilation, also known as endothelial
dysfunction (ED) (Singhal, 2005). ED can be detected prior to the development of
atherosclerotic plaques in both coronary and peripheral vessels and has been implicated in
the pathogenesis of diseases such as hypertension, diabetes, coronary artery disease,
peripheral artery disease, chronic heart disease, and chronic renal failure (Endemann &
Schiffrin, 2004).
In healthy individuals, the quiescent state of the vascular system is maintained by
vasoactive compounds produced from endothelial cells, most notably nitric oxide (NO).
NO bioavailability is regulated by nitric oxide synthase (NOS), primarily located within
caveolae of the cellular plasma membrane (Boo & Jo, 2003). Shear stress, known as the
dragging force of blood on the endothelial cell wall generated by flow, is one of the most
1

important mechanical regulators of endothelial NOS (eNOS) (Fisslthaler, Dimmeler,
Hermann, Busse, & Fleming, 2000). Both laminar and turbulent shear stresses induce
phosphorylation of eNOS, although direct regulatory mechanisms of specific kinases and
phosphorylases have yet to be elucidated.
During endothelial cell activation an early biochemical marker is the loss of NO,
initiating a chronic inflammatory response of the arterial walls. The most notable
disruption in vascular homeostasis is an imbalance in the release of vasoconstrictor and
vasodilator compounds, initiating ED. The bioavailability of this potent vasodilator, NO,
is attenuated in many cardiovascular diseases such as hypertension, obesity, and
atherosclerosis (M. Charakida et al., 2006).
In 1988, researchers described the link between increased risk of cardiovascular
mortality and observed risk factors such as obesity, hypertension, insulin resistance, and
hypercholesterolemia as syndrome X, better known as the metabolic syndrome (MetS) (G.
Reaven, 1988). As a central causative component of MetS, obesity has been associated
with several metabolic alterations (Hutley & Prins, 2005). The World Health Organization
defines obesity as a condition of excess body fat to the extent that health is impaired
(Obesity: Preventing and managing the global epidemic. report of a WHO
consultation.2000). Body mass index (BMI, weight(kg)/height(m)2) has a close correlation
to body fat and obesity-related diseases and is therefore often used to assess obesity (Y.
Wang & Beydoun, 2007). BMI cutoff points of 25 and 30 kg/m2 are used to define
overweight and obesity, respectively.
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In 1994, adipose tissue was recognized as a major site for secretion of protein
signals with the discovery of leptin, helping to establish white adipose tissue (WAT) as an
endocrine organ. Obesity, which is directly related to an individual’s WAT, has recently
been characterized as a state of chronic low-grade inflammation. This review primarily
focuses on two of the most frequently measured pro-inflammatory adipokines, TNF-α and
IL-6, and their impact on endothelial function (EF).
Although elevated levels of TNF-α play a role in numerous functions, a primary
target is endothelial membrane receptors, which stimulate biological activity suggestive of
ED (Ritchie et al., 2004). TNF-α levels are inversely correlated to NO bioavailability (P.
Wang, Ba, & Chaudry, 1994; Bhagat & Vallance, 1997). IL-6, another adipokine often
expressed as a pro-inflammatory marker, has recently received a great deal of attention, in
particular with its release from skeletal muscle and its role as a myokine. IL-6 is thought
to negatively affect EF through an indirect pathway mediated by the stimulation of Creactive protein (CRP) released from the liver (Ritchie et al., 2004). However, it has been
proposed that the role of IL-6 is dependent upon its origin of secretion, such that release
from adipose and skeletal muscle tissue may interact and oppose one another (Pedersen &
Fischer, 2007b). IL-6 secreted from contracting skeletal muscle results in the activation of
anti-inflammatory pathways (Febbraio & Pedersen, 2005).
The pathophysiology of ED includes an impairment of vasodilation initiated by a
pro-inflammatory state. Measurement of specific adipokines and other pro-inflammatory
laboratory markers are considered a good complement to the direct assessment of EF. Due
to a strong association between ED and the initiating stages of atherosclerosis, as well as
3

clinical symptoms such as unstable angina and myocardial infarction (MI), the assessment
of EF is crucial in targeting individuals with impaired vascular reactivity (Vita & Keaney,
2002). Coronary ED has been shown to be an independent predictor of atherosclerotic
disease progression and cardiovascular event rates in individuals with coronary artery
disease (CAD), as well as those without CAD (Halcox et al., 2002; Schachinger, Britten, &
Zeiher, 2000). Since EF can be assessed years before any cardiovascular event, the need
for a non-invasive measure of EF that can be used on multiple occasions during one’s
lifespan to determine the presence and effectiveness of treatment of atherosclerosis is
appealing. Forearm blood flow (FBF), as assessed by venous occlusion strain-gauge
plethysmography can provide non-invasive assessment of EF in peripheral vessels. The
relationship between ED in peripheral arteries is well established and peripheral ED has
also been shown to predict future cardiovascular events (Anderson et al., 1995; Kitta et al.,
2009; Neunteufl et al., 1997; Shechter et al., 2007; Takase, Hamabe, Satomura, Akima,
Uehata, Matsui, Ohsuzu, Ishihara, & Kurita, 2006; Tentolouris et al., 2004; Vita &
Keaney, 2002; Yeboah, Crouse, Hsu, Burke, & Herrington, 2007).
To date, there are no known studies that have evaluated the prognostic impact of
FBF assessed by strain gauge plethysmography in predicting the long-term outcome of
individuals with and without CAD. However, strain gauge plethysmography has been
used to demonstrate relationships among FBF and several cardiovascular disease risk
factors (Ishibashi et al., 2006). Chronic pro-inflammatory conditions, such as obesity can
be significant in the initiation of atherosclerosis. Due to ED being an early event in the
progression of CVD, EF assessment could be of prognostic value since it reflects vascular
4

biology. If ED is associated with the pathogenesis of CVD, it is often proposed that
reversal of ED will reduce the risk for CVD.
The beneficial effects of exercise on reducing risk for CVD are well known.
Studies that have assessed the effects of exercise on ED have strengthened decisions to
employ exercise training as an important therapy treatment for ED. As previously
described, increasing shear stress on endothelial cells stimulates secretion of NO leading to
smooth muscle cell relaxation and subsequent vascular dilation. Data suggest that regular
exercise using a large muscle mass can induce adaptations in non-exercising limbs, which
enhance EF (Kingwell, Sherrard, Jennings, & Dart, 1997). Important findings such as this
justify the evaluation of FBF with common aerobic exercise modalities such as cycling and
walking.
Many studies have shown an exercise training effect on EF with subjects who were
at higher risk for CVD (Watts, Beye, Siafarikas, O'Driscoll et al., 2004; Woo et al., 2004;
Hamdy et al., 2003; Schjerve et al., 2008; Higashi et al., 1999; Maiorana et al., 2001;
Walsh, Yong et al., 2003). Interestingly, Green et al. (2003) investigated whether EF
improvements observed with exercise resulted from short term repetitive exercise bouts or
exercise associated improvements in CVD risk factor profiles (Green et al., 2003). The
study suggested that these changes in EF are not exclusively related to the effect that
exercise has on CVD risk factors, further demonstrating the impact exercise training has on
the vascular system, with its frequent, periodic increase in shear stress.
Although most exercise training studies have evaluated subjects with an increased
risk for CVD disease, a limited number of studies have evaluated the effect of exercise
5

training on EF in healthy subjects (Clarkson et al., 1999; Goto et al., 2003; Higashi et al.,
1999; Rakobowchuk et al., 2008; Bergholm et al., 1999; Goto et al., 2003; Rakobowchuk
et al., 2005). Moreover, these studies are not in complete agreement that EF is enhanced
following exercise training in healthy individuals. Currently, studies appear to support an
improvement in EF in healthy individuals following moderate-intensity aerobic exercise
training. These positive changes in EF with moderate-intensity training are not well
supported in high-intensity aerobic exercise training or strength exercise training models.
While most studies examine EF following exercise training, EF following acute
exercise has not been extensively researched. Only a few studies have evaluated the effect
of a single bout of exercise on EF in healthy individuals (Baynard, Miller, & Fernhall,
2003; Bousquet-Santos, Soares, & Nobrega, 2005; Rognmo et al., 2008). Although all of
the studies demonstrated an increased EF measure immediately post-exercise, BousquetSantos et al. suggested a return of EF measures to baseline levels within 2 hours of
exercise (Bousquet-Santos, Soares, & Nobrega, 2005). Previous studies have presented
important findings in further understanding the effects of acute exercise on EF. However,
an extensive review of literature has produced no study in which the extended time-course
for EF following a single bout of maximal exercise is shown, especially in obese
individuals. This is of primary importance considering a previous study has demonstrated
an exercise-induced effect up to 24 hours of inflammatory biomarkers that may have an
effect on the EF (Louis, Raue, Yang, Jemiolo, & Trappe, 2007). The impact of
inflammatory markers post-exercise could be crucial in assessing EF post-exercise, where
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there does not appear to be a standardized optimal time before EF is assessed following a
training program’s last exercise bout.
The critical effect of endothelial wall activation and its associated role in initiating
atherosclerosis warrants further research of the mediating receptors and circulating agents
that allow for the control of vascular homeostasis. Assessing EF and the biomarkers
associated with its control is vital in understanding interventions that may help not only
slow the progression of CVD but negate specific CVD risk factors. The underlying
mechanisms that control EF changes following exercise training have received a large
amount of attention and continue to be evaluated. PA has been shown as an important
mediator for improving EF through the generation of shear stress. This study aims to
investigate an extended time course of acute exercise-induced adaptation on EF. The time
course of exercise induced adaptations on EF has been evaluated in only a few studies
giving rise to the need for a similar study in healthy and obese subjects. Exercise training
study results are inconclusive as to whether the exercise interventions improve EF or
whether improvements in EF are simply a reflection of the alterations from the last
exercise bout performed. Findings may help establish an optimal time point to assess EF
following an exercise training program and also allow researchers to further understand the
impact an acute exercise bout can have on regulating the vasodilatory capacity of the
arterial wall.

7

Review of Literature

Atherosclerotic cardiovascular disease (CVD) is the leading cause of death
in the United States, and has a 50% prevalence risk after the age of 40 years. (Lloyd-Jones
et al., 2004). Atherosclerosis is distinguished by increased thickening of the arterial wall,
accounting for approximately three-fourths of all CVD deaths (Rosamond et al., 2007).
Pathological changes in arteries that occur in children and young adults prior to the onset
of adult clinical symptoms have indicated a long preclinical phase of atherosclerosis. The
clinical signs of CVD are final expressions of a disease process that has been progressing
for decades. It is now known that early life events have a lasting impact on the
development of atherosclerosis and risk for CVD (Napoli et al., 1999; Singhal, 2005;
Skilton & Celermajer, 2006).
One of the earliest subclinical stages in the atherosclerotic process is impairment of
endothelium-dependent vasodilation, also known as endothelial dysfunction (ED) (Singhal,
2005). ED can be detected prior to the development of atherosclerotic plaques in both
coronary and peripheral vessels and has been implicated in the pathogenesis of diseases
such as hypertension, diabetes, coronary artery disease, peripheral artery disease, chronic
heart disease, and chronic renal failure (Endemann & Schiffrin, 2004). Vascular
homeostasis is regulated by the endothelium, a single layered paracrine organ lining the
8

blood vessels with a pleiotropic role consisting of modulating vascular tone, cellular
adhesion, thromboresistance, smooth muscle cell proliferation, and vessel wall
inflammation (Deanfield, Halcox, & Rabelink, 2007). The earliest studies on the
significance of endothelial cells investigated the production and release of compounds
effecting vascular tone. In 1980, experiments of Furchgott and Zawadzki were the first to
demonstrate the action of acetylcholine on endothelial cells, which released a substance
targeting smooth muscle and initiated relaxation (Furchgott & Zawadzki, 1980). The
biological activity of this endothelial-derived relaxing factor (EDRF) was later compared
to nitric oxide (NO), where the EDRF and NO relaxation of bioassay tissues were shown
to be significantly similar (Palmer, Ferrige, & Moncada, 1987). It was also suggested that
both EDRF and NO were inhibited by oxyhemoglobin and stimulated by superoxide
dismutase (SOD), thus providing evidential support in proposing that EDRF and NO were
the same (Ignarro, Buga, Wood, Byrns, & Chaudhuri, 1987; Palmer et al., 1987).
MECHANISMS REGULATING ENDOTHELIAL FUNCTION
In healthy individuals, the quiescent state of the vascular system is maintained by
vasoactive compounds produced from endothelial cells, most notably NO. NO
bioavailability is regulated by nitric oxide synthase (NOS), primarily located within
caveolae of the cellular plasma membrane (Boo & Jo, 2003). When activated, NOS
mobilizes, converting molecular oxygen and L-arginine to NO and L-citrulline. Three
tissue specific NOS isoforms (neuronal NOS (nNOS), inducible NOS (iNOS), and
endothelial NOS (eNOS)) have been identified. NO derived from eNOS is essential in
regulating cardiovascular homeostasis (M. Charakida, Deanfield, & Halcox, 2006;
9

Forstermann & Munzel, 2006). Endothelium-derived NO diffuses into adjacent smooth
muscle cells activating soluble guanylyl cyclase (sGC), which synthesizes cyclic guanosine
monophosphate (cGMP) from guanosine triphosphate (GTP) (M. Charakida et al., 2006;
Murad, 2006). cGMP is an intracellular second messenger with many roles, one of which
includes the activation of intracellular protein kinases. Activated protein kinases decrease
the concentration of cytosolic calcium, which leads to the dephosphorylation of smooth
muscle myosin light chain, thus vascular relaxation (Murad, 2006).
There are many eNOS agonists, which include humoral, mechanical, metabolic,
and pharmacological stimuli. Initially, the proposed stimulation of eNOS consisted of a
simple calcium (Ca2+) dependent model, in which activation of eNOS was controlled by
Ca2+/calmodulin (CaM) binding (Fleming & Busse, 2003; Moncada & Higgs, 1993;
Mount, Kemp, & Power, 2007). However, it has since been shown that a wide variety of
eNOS stimuli regulate NO production through more complex pathways including proteinprotein interactions and site-specific phosphorylation involving kinases and
phosphorylases (Boo et al., 2002; Fleming & Busse, 2003; Mount et al., 2007). Shear
stress, known as the dragging force of blood on the endothelial cell wall generated by flow,
is one of the most important mechanical regulators of eNOS (Fisslthaler, Dimmeler,
Hermann, Busse, & Fleming, 2000). Both laminar and turbulent shear stresses induce
phosphorylation of eNOS, although direct regulatory mechanisms of specific kinases and
phosphorylases have yet to be elucidated.
In brief, shear stress activates guanine nucleotide binding (G) protein’s-coupled
transmembrane receptor, which induces activation of phosphoinositide 3-kinase (PI3K).
10

PI3K indirectly activates 3-phosphoinositide-dependent protein kinase 1 and 2 (PDK1 and
PDK2, respectively) (Boo et al., 2002; Sessa, 2004). PDK1 and PDK2 phosphorylate
protein kinases responsible for phosphorylation of eNOS at specific amino acid sites. Thus
far, five eNOS phosphorylation sites have been identified, the most notable recognized as
serine 1177 (Ser1177) (Boo & Jo, 2003; Mount et al., 2007). Other phosphorylation sites
stimulated by shear stress include serine 114 (Ser114) and serine 633 (Ser633) (Mount et al.,
2007).
Although NO is widely known for its vasodilatory effect, there are other actions
elicited by NO production that are beneficial such as regulation of smooth muscle cell
proliferation and inhibition of vascular platelet adhesion (de Graaf et al., 1992; Freedman
et al., 1997; Ignarro et al., 2001; Michelson et al., 1996; Stein, Fabry, Murphy, & Hart,
1995). Along with impaired endothelium-dependent vasodilation, increased vascular
smooth muscle cell proliferation is a familiar characteristic of atherosclerosis. Growth
factors necessary for cellular reproduction include polyamines, such as putrescine,
spermidine, and spermine. NO has been shown to inhibit ornithine decarboxylase, an
enzyme responsible for converting the amino acid ornithine to putrescine (Ignarro et al.,
2001). Research has also suggested that NO prevents thrombus formation through
inhibition of platelet aggregation (de Graaf et al., 1992; Freedman et al., 1997; Michelson
et al., 1996). NO production has also been shown to inhibit surface platelet P selectin
(Freedman et al., 1997; Michelson et al., 1996). P selectin, a cell adhesion molecule, is
secreted from activated platelets and is responsible for increasing platelet adhesion to
monocytes and stimulating tissue factor (Freedman et al., 1997). Monocytes and tissue
11

factor can both exacerbate atherosclerosis by increasing arterial plaque and coagulation of
blood, respectively.
During endothelial cell activation an early biochemical marker is the loss of NO,
initiating a chronic inflammatory response of the arterial walls. The most notable
disruption in vascular homeostasis is an imbalance in the release of vasoconstrictor and
vasodilator compounds, initiating ED. The bioavailability of this potent vasodilator, NO,
is attenuated in many cardiovascular diseases such as hypertension, obesity, and
atherosclerosis (M. Charakida et al., 2006).
This review will focus primarily on adipokines and the impact they have in
regulating NO bioavailability and thus vascular reactivity. Although reactive oxygen
species (ROS) are not discussed in this review, they do exert a significant influence on NO
bioavailability and future research in this area will be critical in helping clarify the
relationship between NO and endothelial function (EF).
METABOLIC SYNDROME AND OBESITY
In 1988, researchers described the link between increased risk of cardiovascular
mortality and observed risk factors such as obesity, hypertension, insulin resistance, and
hypercholesterolemia as syndrome X, better known as the metabolic syndrome (MetS) (G.
Reaven, 1988). Individuals diagnosed with MetS were identified for an early intervention
in an attempt to decrease the development of type 2 diabetes or CVD (G. M. Reaven,
2005). Today, MetS is identified as having three of five criteria (abdominal obesity,
impaired fasting glucose, high triglyceride and low HDL-cholesterol concentrations, and
increased blood pressure) determined by the Adult Treatment Panel III of the National
12

Cholesterol Education Program (G. M. Reaven, 2005). Current data used for extrapolative
analysis project that nearly 40% of the world’s population will be affected by MetS by
2020 (New developments in metabolic syndrome. proceedings of the 1st conference of the
paul hamel institute. 7-8 june 2004, monaco.2005). As a central causative component of
MetS, obesity has been associated with several metabolic alterations (Hutley & Prins,
2005). While obesity is the primary focus of this review, each component of MetS has the
potential to independently affect EF.
The World Health Organization defines obesity as a condition of excess body fat to
the extent that health is impaired (Obesity: Preventing and managing the global epidemic.
report of a WHO consultation.2000). Body mass index (BMI, weight(kg)/height(m)2) has
a close correlation to body fat and obesity-related diseases and is therefore often used to
assess obesity (Y. Wang & Beydoun, 2007). BMI cutoff points of 25 and 30 kg/m2 are
used to define overweight and obesity, respectively. The prevalence of obesity has more
than doubled in the last thirty years, accounting for approximately 32.4% of obese adults in
the United States (Y. Wang & Beydoun, 2007). Using linear regression models, Wang and
Beydoun suggested that by 2015 the prevalence of obesity in adults and adolescents will
reach 40.8 and 22.7 percent, respectively (Y. Wang & Beydoun, 2007).
Until recently, white adipose tissue’s (WAT) primary role was thought to be energy
storage. In 1994, adipose tissue was recognized as a major site for secretion of protein
signals with the discovery of leptin, helping to establish WAT as an endocrine organ. Over
50 protein signals are now known to be secreted from WAT and various functional roles
have led researchers to collectively name them ‘adipokines’ (Trayhurn & Wood, 2004).
13

The pleiotropic role of adipokines has helped establish WAT’s elaborate communication
system with other tissues and organs. Obesity, which is directly related to an individual’s
WAT, has recently been characterized as a state of chronic low-grade inflammation.
Several mechanisms have been proposed to help explain this phenomenon. These include:
a) the elevation of obesity-related adipokines with proinflammatory functional properties
(Fantuzzi, 2005; Lau, Dhillon, Yan, Szmitko, & Verma, 2005; Ritchie, Ewart, Perry,
Connell, & Salt, 2004; Wisse, 2004), b) the reduced anti-inflammatory function of insulin
as a result of the increased obesity related adipokines (Bruun, Verdich, Toubro, Astrup, &
Richelsen, 2003; Caballero, 2003; Fantuzzi, 2005; Fasshauer & Paschke, 2003; Lau et al.,
2005; Ritchie et al., 2004; Wisse, 2004), c) the increased production of free radicals as a
result of oxidative stress (Ritchie et al., 2004), and d) the hypoxic condition of adipocytes
as WAT increases disproportional to its vascular network (Trayhurn & Wood, 2004).
ADIPOKINES AND NITRIC OXIDE REGULATION
During the last 15 years, many pro-inflammatory adipokines have been discovered
including interleukin (IL) 1βeta, IL-6, IL-8, IL-10, tumor necrosis factor-α (TNF-α),
vascular endothelial growth factor (VEGF), and leptin (Trayhurn & Wood, 2005). This
review will primarily focus on two of the most frequently measured pro-inflammatory
adipokines, TNF-α and IL-6, and their impact on EF.
TNF-α is biologically active as a 17 kDa protein involved in the escalation of a proinflammatory state (Ronti, Lupattelli, & Mannarino, 2006). BMI and percent body fat are
both positively correlated to plasma TNF-α (Ritchie et al., 2004). Although elevated levels
of TNF-α play a role in numerous functions, a primary target is endothelial membrane
14

receptors, which stimulate biological activity suggestive of ED (Ritchie et al., 2004).
TNF-α levels are inversely correlated to NO bioavailability. Wang et al. revealed that 2
hours of in vivo administered TNF-α in male Sprague-Dawley rats significantly decreased
NO synthesis and release, leading to impairment of endothelium-dependent vasodilation
for up to 80 minutes (P. Wang, Ba, & Chaudry, 1994). Bhagat et al. infused TNF-α for
one hour in healthy males and females 19 – 40 years of age (Bhagat & Vallance, 1997).
The researchers suggested that endothelium-dependent vasodilation was attenuated up to
six hours. However, in this study, it is important to note that prior to six hours only one
post TNF-α measurement was taken, which was obtained at one hour. Therefore, it is not
known if the return to baseline endothelium-dependent vasodilation occurred prior to six
hours. These findings suggest that TNF-α effects endothelium-dependent vasodilation in a
time-dependent manner. Possible explanations for the depression in endotheliumdependent vasodilation with TNF-α include inhibition of receptor-mediated release of NO
from endothelial cells, degradation of NOS mRNA, and increases in endothelin (ET)
(Bhagat & Vallance, 1997; Ritchie et al., 2004; P. Wang et al., 1994). TNF-α has also
been shown to stimulate adhesion molecules such as intracellular cell-adhesion molecule-1
(ICAM-1) and vascular cell adhesion molecule-1 (VCAM-1) (Ritchie et al., 2004; Ronti et
al., 2006). These adhesion molecules enhance monocyte attachment to the endothelial wall
(Ronti et al., 2006). The monocytes then migrate to the subendothelial space where they
become foam cells. Foam cells contain oxidized low density lipoprotein (LDL) and can
lead to the development and progression of atherosclerosis.
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ET is released from endothelial cells and binds to two receptor subtypes, ETA and
ETB, located on smooth muscle cells, adjacent to the endothelial cells (Bohm & Pernow,
2007). The receptors are coupled to a G-protein, which stimulates the production of
intracellular inositol triphosphate (IP3). Subsequently, Ca++ is released from the
sarcoplasmic reticulum, leading to phosphorylation of smooth muscle myosin light chain,
thus vascular constriction. ETB receptors can also be found on endothelial cells and when
stimulated result in the production of cGMP and secretion of NO, leading to vascular
relaxation (Bohm & Pernow, 2007). G-proteins can have different functional roles
depending on the stimulation of various subunits. G-proteins are heterodimers made of α,
β, and γ subunits, each with several isoforms (Neer, 1994; Oldham & Hamm, 2006). The
various G-protein types give rise to a wide range of specific cellular responses from
external stimuli. It has been suggested that the Gαs and Gαq families are specific in
production of cGMP and IP3, respectively (Neer, 1994; Oldham & Hamm, 2006). In a
healthy vessel, the net balance effect of ETA and ETB activation is vascular relaxation. In a
disease condition such as ED, the sensitivity of ET is much more pronounced, resulting in
an upregulation of the vasoconstrictor ETB receptor located on smooth muscle cells (Bohm
& Pernow, 2007). ET has also been shown to stimulate the production of both TNF-α and
IL-6, which in turn exacerbate the production of ET.
IL-6, another adipokine often expressed as a pro-inflammatory marker, has recently
received a great deal of attention, in particular with its release from skeletal muscle and its
role as a myokine. Although IL-6 is positively correlated with obesity and significantly
decreases with weight loss, secretion from adipose tissue only accounts for ~10% of total
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concentration (Ronti et al., 2006). Plasma IL-6 concentration is positively correlated with
the development of CVD (Avogaro & de Kreutzenberg, 2005). Although IL-6 is thought
to negatively affect EF, it has been suggested that this occurs primarily through an indirect
pathway mediated by the stimulation of C-reactive protein (CRP) released from the liver
(Ritchie et al., 2004). Recent evidence has shown IL-6 to be the only cytokine secreted
from skeletal muscle and be released into circulation following exercise (Pedersen &
Fischer, 2007a). IL-6 had previously been recognized as a pro-inflammatory cytokine that
contributed to insulin resistance. Mechanistically, an exercise-induced increase in IL-6
failed to explain the increase in post-exercise insulin action. Researchers then began to
suggest that the pro-inflammatory association with IL-6 was primarily due to positive
correlations in cohort studies, animal studies, and in vitro studies that had
supraphysiological concentrations, none of which best represent in vivo human
physiological studies (Pedersen & Fischer, 2007b). It is important to distinguish between
acute versus chronic secretion of IL-6 and different functional properties that may be
associated with each. It has been proposed that the role of IL-6 is dependent upon its
origin of secretion, such that release from adipose and skeletal muscle tissue may interact
and oppose one another (Pedersen & Fischer, 2007b). IL-6 secreted from contracting
skeletal muscle results in the activation of anti-inflammatory pathways (Febbraio &
Pedersen, 2005). Muscle derived IL-6 is linked to an increase in well-known antiinflammatory cytokines (e.g. interleukin 10 (IL-10) and interleukin 1 receptor antagonist
(IL-1ra)) as well as inhibition of TNF-α. Whereas, IL-6 released from adipose tissue is
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associated with an increase in the pro-inflammatory marker CRP (Avogaro & de
Kreutzenberg, 2005; Pedersen & Fischer, 2007b; Ritchie et al., 2004).
CRP is thought to be one of the strongest independent predictors of CHD and is
significantly correlated to body fat, MetS, and type 2 diabetes (Lau et al., 2005; Verma et
al., 2002). CRP directly alters EF through augmented expression of adhesion molecules
VCAM-1 and ICAM-1, as well as increasing secretion of ET (Lau et al., 2005; Pasceri,
Willerson, & Yeh, 2000). CRP further exacerbates its production through a positive
feedback mechanism in which it increases expression of IL-6. CRP has also been shown
to down regulate eNOS mRNA, attenuating NO production (Verma et al., 2002). This
impact is mediated through a reduction in eNOS mRNA half-life, which has been
suggested to significantly decrease from 24 to 14 hours in plate grown endothelial cells
treated with CRP.
ASSESSMENT OF ENDOTHELIAL FUNCTION
As previously discussed, the pathophysiology of ED includes an impairment of
vasodilation initiated by a pro-inflammatory state. Measurement of specific adipokines,
cellular adhesion molecules, and other pro-inflammatory laboratory markers are considered
a good complement to the direct assessment of EF. Currently, there are three primary
methods of EF assessment. These include coronary angiography, high-resolution vascular
ultrasonography, and venous occlusion strain-gauge plethysmography.
Coronary Angiography
Direct measurement through coronary angiography is an invasive in situ test that
poses high risk for cardiovascular events such as myocardial infarction or stroke
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(Kasprzak, Klosinska, & Drozdz, 2006). Researchers infuse acetylcholine into the
coronary artery before attempting to detect diameter change. Acetylcholine increases the
release of NO by activating muscarinic receptors located on the endothelial membrane. An
increased risk for atherosclerosis is often designated in areas where vasodilation does not
occur (Kasprzak et al., 2006).
High Resolution Vascular Ultrasonography
ED can also occur in peripheral conduit arteries, which allows for the non-invasive
in vivo assessment of a more accessible vessel, such as the brachial artery. It is presumed
that ED through brachial artery assessment is closely related to ED in coronary arteries
(Vita & Keaney, 2002). Flow-mediated dilation (FMD) of the brachial artery is measured
through high resolution vascular ultrasonography and is the most commonly used test for
assessing EF. Briefly, the brachial artery diameter in the upper arm is measured from
brightness (B) mode ultrasound images (Patel & Celermajer, 2006; Watts, Beye,
Siafarikas, Davis et al., 2004). Ultrasound transducers must be greater than 7 MHz in
order to obtain optimal resolution (Patel & Celermajer, 2006). Baseline measurements,
which include diameter and blood flow velocity, are recorded for one minute. The FMD is
induced by endothelial cells detecting changes in sheer stress during increasing turbulent
flow following brief ischemia. Ischemia is caused by rapid inflation of a
sphygmomanometer cuff wrapped around the forearm. The cuff is inflated to 250 – 300
mmHg for at least 4.5 minutes (Kasprzak et al., 2006; Patel & Celermajer, 2006; Watts,
Beye, Siafarikas, O'Driscoll et al., 2004). Following cuff deflation, recordings are again
measured for 1 minute. The percent change in brachial artery diameter from baseline to
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45-60 seconds after deflation is recorded as FMD (Williams et al., 2005). After measuring
FMD following brief ischemia, FMD is measured following sublingual administration of
nitroglycerin (NTG). NTG causes vascular relaxation in an endothelium-independent
manner and is often used as a control against the ischemic condition. At baseline, the ideal
vessel diameter is 2.5 – 5 mm. A larger vessel may not be associated with significant
increases in vasodilation, even when normal EF exists (Patel & Celermajer, 2006). It is
often hard to obtain an accurate image in a vessel smaller than 2.5 mm. In adult subjects,
vessel size is not often an issue, however, in children the artery of choice becomes the
femoral artery (Patel & Celermajer, 2006). Due to differences in FMD with different size
vessels, it is recommended that all values be reported as an absolute change in diameter
(Kasprzak et al., 2006). Variations in FMD also exist between fasting and post-prandial
conditions, therefore, it is important to test individuals in a fasting state.
FMD values are different among diverse populations. Individual’s with known
CHD, Type 2 diabetes, and healthy volunteers have FMD values that vary between -1.3 to
14%, 0.75 to 12%, and 0.2 to 21%, respectively (Berry, Skyrme-Jones, & Meredith, 2000;
Kasprzak et al., 2006). These variations in baseline FMD values make it difficult in
defining normal ranges. Researchers attribute these differences to arterial occlusion times,
positioning of the occlusion cuff, and time point of vessel measurement following cuff
deflation (Berry et al., 2000). Various studies have used an occlusion cuff on the upper
arm rather than the forearm. When this occurs, brachial artery diameter measurements
occur in the forearm rather than the upper arm. If an upper arm cuff is used to assess FMD
then occlusion time must last for at least 5 minutes (Berry et al., 2000). Researchers have
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suggested that brachial artery FMD was significantly greater when upper arm occlusion
was used compared to forearm occlusion (Agewall et al., 2001; Berry et al., 2000; Peretz et
al., 2007). Berry et al. also suggested that peak FMD occurred at different times
depending on cuff placement (Berry et al., 2000). FMD peaked at 71 seconds with upper
arm occlusion compared to 49 seconds with forearm occlusion. Participants in both upper
and lower arm occlusion groups were separated based on their time to peak FMD.
Although most subjects with forearm occlusion reached peak FMD within 60 seconds,
there were still 6% of participants who did not see a peak FMD until after 60 seconds. Of
those participants who had their upper arm occluded to assess FMD, 69% of the subjects
experienced peak FMD after 60 seconds. These results have been shown in a more recent
study and give rise to concern for variations found in studies that use the first 60 seconds to
assess changes in FMD as well as comparing results using different arm occlusion sites
(Peretz et al., 2007). While the brachial artery is often used to measure changes in FMD,
the radial artery can also be measured following forearm occlusion. Agewall et al.
compared FMD changes in the brachial and radial arteries following occlusion of both the
upper arm and forearm (Agewall et al., 2001). FMD was greatest in the radial artery,
regardless of where cuff occlusion occurred.
Venous Occlusion Strain-Gauge Plethysmography
Another non-invasive in vivo tool used to assess EF that is practical and relatively
low-cost is venous occlusion strain-gauge plethysmography. In many laboratories, it is the
preferred method in assessing EF because it does not require a radiological technologist as
does the vascular ultrasonography. Strain-gauge plethysmography works similar to high
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resolution vascular ultrasonography in measuring post-occlusive reactive hyperemia.
Following an overnight fast, subjects are positioned in a supine position and acclimatize
for at least thirty minutes (Thijssen, Bleeker, Smits, & Hopman, 2005). The arm is placed
approximately 5 cm above the level of the heart and a sphygmomanometer cuff is placed
around the upper arm. The cuff is attached to a rapid cuff inflator. A mercury-in-silastic
strain gauge is placed on the largest portion of the forearm. A smaller cuff is placed
around the wrist and inflated to super-systolic pressures prior to any measurement in
attempt to minimize the contribution of hand blood flow, which has a different control
function compared to forearm blood flow (FBF) (Leslie et al., 2004). This allows forearm
volume to increase in conjunction with an increase in FBF. The increased forearm volume
can be detected through increases in forearm circumference measured by changes in the
mercury-in-silastic strain gauge (Leslie et al., 2004). A baseline measurement is recorded
as the upper arm cuff is inflated above venous pressure but below arterial pressure. This
allows venous outflow to be obstructed while arterial inflow remains the same. The upper
arm cuff is inflated for ten seconds and deflated for five seconds while FBF is measured.
Averages of five measurements are taken. Peak FBF is measured following post-occlusive
hyperemia induced by inflating the upper cuff to super-systolic pressure for at least 5
minutes before FBF measurement is taken.
Technical considerations that should be considered for using venous occlusion
strain-gauge plethysmography include appropriate venous occlusion pressure and duration
of venous occlusion. It has been reported that several studies apply a standard venous
occlusion of 50 mmHg while others employ a value dependent on subject’s diastolic
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pressure (Alomari et al., 2004). Researchers suggested that venous occlusion of 7, 14, 21,
28, and 35 mmHg below diastolic pressure had a stepwise decrease in venous capacitance,
respectively (Alomari et al., 2004). The study also compared venous outflow with the
same pressure values and illustrated a stepwise decrease as occlusion pressure decreased,
suggesting a strong positive relationship between venous capacitance and venous outflow.
Forearm inflow was not altered, providing a significant role for occlusion pressure as
forearm circumference is related to venous outflow. Alomari et al. also showed that peak
forearm blood inflow and venous outflow were both significantly correlated to
cardiovascular fitness (Alomari et al., 2004). The positive relationship between peak
oxygen consumption (VO2peak) and both arterial inflow and venous outflow, clearly
demonstrate the ability for arteries and veins to deliver nutrients and remove waste
metabolites from blood during increasing levels of muscle contraction, potentially reducing
muscular fatigue.
CLINICAL SIGNIFICANCE OF ENDOTHELIAL FUNCTION
Due to a strong association between ED and the initiating stages of atherosclerosis,
as well as clinical symptoms such as unstable angina and myocardial infarction (MI), the
assessment of EF is crucial in targeting individuals with impaired vascular reactivity (Vita
& Keaney, 2002). Coronary ED has been shown to be an independent predictor of
atherosclerotic disease progression and cardiovascular event rates in individuals with
coronary artery disease (CAD), as well as those without CAD (Halcox et al., 2002;
Schachinger, Britten, & Zeiher, 2000). Shachinger et al. evaluated the long term outcome
(6.7±3.2 years) of individuals who were undergoing routine evaluation of chest pain or
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percutaneous transluminal coronary angioplasty for single vessel disease (Schachinger et
al., 2000). FMD measured by coronary angiography demonstrated a significant inverse
relationship between the incidence of cardiovascular events and both flow-dependent and
NTG-induced vasodilation. To determine if the incidence of cardiovascular events was
inversely related to endothelial cell or smooth muscle cell function, the investigators
normalized flow-dependent vasodilation to NTG-induced vasodilation. After
normalization of NTG-induced vasodilation, flow-dependent vasodilation significantly
predicted cardiovascular events, suggesting that impaired coronary vasodilation was
directly related to endothelial cell function (Schachinger et al., 2000). Halcox et al.
examined the change in coronary vascular resistance (CVR) during the arterial infusion of
the endothelial-dependent vasodilator, acetylcholine (ACH), in patients with angiographic
evidence of irregularity, as well as individuals with angiographically smooth coronary
arteries (Halcox et al., 2002). The investigators demonstrated that individuals with the
greatest change in CVR were more likely to have a cardiovascular event-free survival
(46±3 months), independent of the presence of CAD.
Although the relationship between CAD and coronary ED is well supported, the
invasive measure is not feasible in healthy individuals or even those with only suspected
coronary ED. Since EF can be assessed years before any cardiovascular event, the need
for a non-invasive measure of EF that can be used on multiple occasions during one’s
lifespan to determine the presence and effectiveness of treatment of atherosclerosis is
appealing. FMD and FBF, as assessed by high resolution vascular ultrasonography and
venous occlusion strain-gauge plethysmography, respectively, can provide non-invasive
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assessment of EF in peripheral vessels. As previously mentioned, the relationship between
ED in human coronary and peripheral arteries is well established and peripheral ED has
also been shown to predict future cardiovascular events (Anderson et al., 1995; Kitta et al.,
2009; Neunteufl et al., 1997; Shechter et al., 2007; Takase, Hamabe, Satomura, Akima,
Uehata, Matsui, Ohsuzu, Ishihara, & Kurita, 2006; Tentolouris et al., 2004; Vita &
Keaney, 2002; Yeboah, Crouse, Hsu, Burke, & Herrington, 2007).
Anderson et al. were the first to demonstrate a relationship between percent
diameter changes in two different vascular beds of the same individual (Anderson et al.,
1995). The investigators demonstrated a significant positive relationship with brachial and
coronary vasodilation. The relationship was shown in patients with and without CAD,
suggesting that ED is not restricted to vessels with evident atherosclerosis and may be an
early “functional expression” of the atherosclerotic process (Anderson et al., 1995). Other
studies supported FMD of the brachial artery as a useful non-invasive tool to measure EF
and provided evidence that that ED may be an early “functional expression” of
atherosclerosis (Kitta et al., 2009; Neunteufl et al., 1997; Takase, Hamabe, Satomura,
Akima, Uehata, Matsui, Ohsuzu, Ishihara, & Kurita, 2006; Yeboah, Crouse, Hsu, Burke, &
Herrington, 2007). Neunteufl et al. reported data from a multiple regression stepwise
analysis suggesting that brachial artery FMD had a significant inverse correlation with the
severity of CAD (Neunteufl et al., 1997). Subjects from the study with CAD had
significantly less FMD than non-CAD subjects. NTG induced vasodilation was not
significantly different between CAD and non-CAD subjects, suggesting that impairment in
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vascular relaxation in CAD subjects was directly related to endothelial cell function as
opposed to smooth muscle cell activity (Neunteufl et al., 1997).
More recently, Takase et al., suggested that the brachial artery’s response to ACH
was significantly correlated to the response of the coronary artery to ACH in individuals
with low to moderate cardiovascular risk factors and only slight suspicion of CAD
(Takase, Hamabe, Satomura, Akima, Uehata, Matsui, Ohsuzu, Ishihara, & Kurita, 2006).
The investigators followed these same individuals for 53 ± 17 months and demonstrated
that the peripheral vessel’s dilatory capacity was useful in predicting the incident of longterm cardiovascular events. Employing the brachial artery’s dilation capacity as a means
to predict cardiovascular events has been well documented in other studies (Kitta et al.,
2009; Shechter et al., 2007; Yeboah, Crouse, Hsu, Burke, & Herrington, 2007).
Shechter et al. assessed EF between healthy and stable CVD subjects (Shechter et
al., 2007). Brachial artery FMD was significantly lower in CVD subjects compared to
healthy controls and there was no significant difference in NTG-induced dilation between
the two groups. All subjects were divided into groups based on cardiovascular risk factors
such as gender, hypertension, hyperlipidemia, smoking history, diabetes mellitus and
family history. FMD was significantly lower in males compared to females and nonsignificantly lower in diabetic compared to non-diabetic subjects (Shechter et al., 2007).
This study reported no significant correlation between FMD and hypertension,
hyperlipidemia, smoking and family history. When FMD was analyzed against an
individual’s number of CVD risk factors, there was a significant inverse relationship.
Healthy individual’s baseline brachial artery was significantly larger compared to the CVD
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patients. In addition, the baseline brachial artery diameter and FMD had a significant
inverse correlation. The investigators speculated that large diameter arteries are unable to
reach maximal dilation, further illustrating the impaired vascular function of the CVD
patients (Shechter et al., 2007). Of note, both healthy and CVD subjects had mean
baseline brachial artery diameters greater than 5 mm, which is larger than the
recommended size when assessing FMD. Shechter et al. followed up all subjects 15 ± 2
months for CVD endpoints (e.g. all-cause mortality, MI, hospitalization for heart failure or
angina pectoris, cerebrovascular accident, CABG and percutaneous coronary interventions)
(Shechter et al., 2007). CVD endpoints were significantly more frequent in subjects who
had less than 6% brachial artery FMD change in response to reactive hyperemia.
Yeboah et al. were the first to evaluate brachial artery FMD as a predictor of
cardiovascular events in older adults aged 72 to 98 years (Yeboah, Crouse, Hsu, Burke, &
Herrington, 2007). Study participants were contacted biannually during a five year followup period to determine if any cardiovascular event had occurred. The investigators
suggested that FMD was a significant predictor of cardiovascular events, even after
adjusting for baseline CVD status and CVD risk factors including age and gender. Those
individuals who had brachial artery FMD greater than the sex-specific medians were more
likely to have event-free survival rates for cardiovascular events (Yeboah, Crouse, Hsu,
Burke, & Herrington, 2007). This study was also the first to suggest that brachial artery
diameter was inversely related to the incidence of cardiovascular events in older
individuals. The relationship between FMD and baseline diameter size of the brachial
artery was not shown in this study. However, these findings are similar to those reported
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by Shechter et al. (2007), indicating that although individuals with a larger brachial artery
baseline diameter size may not experience maximal FMD, the vascular reactivity is still
significantly larger than individuals who experience a follow-up cardiovascular event.
This further supports the view that impaired FMD is a measure of the early “functional
expression” of the atherosclerotic process, independent of the brachial artery baseline
diameter size.
To date, there are no known studies that have evaluated the prognostic impact of
FBF assessed by strain gauge plethysmography in predicting the long-term outcome of
individuals with and without CAD. However, strain gauge plethysmography has been
used to demonstrate relationships among FBF and several cardiovascular disease risk
factors. Ishibashi et al. examined FBF on individuals who were apparently healthy, with
no known history of CVD and free from medications for hypertension, diabetes, and
hyperlipidemia (Ishibashi et al., 2006). Several cardiovascular disease risk factors were
assessed, which included age, hypertension, hypercholesterolemia, diabetic mellitus,
smoking, obesity, and a family history of CVD. The investigators suggested that duration
of hyperemia, when measuring FBF following the release of an upper arm cuff, was
significantly shorter in individuals with CVD risk factors (Ishibashi et al., 2006). Longterm studies are warranted that evaluate the duration of hyperemia with clinically evident
atherosclerotic disease later in life.
Alarmingly, it is speculated that ED is present in asymptomatic children as
suggested by the existence of fatty streaks in postmortem studies (Napoli et al., 1999). As
previously described, there is a strong relationship between ED and pro-inflammatory
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conditions. Children with acute respiratory infections, a pro-inflammatory state, have
decreased brachial artery FMD that has been shown to be reversible (M. Charakida et al.,
2005). However, chronic pro-inflammatory conditions, such as obesity can be significant
in the initiation of atherosclerosis. Due to ED being an early event in the progression of
CVD, EF assessment could be of prognostic value since it reflects vascular biology.
If ED is associated with the pathogenesis of CVD, it is often proposed that reversal
of ED will reduce the risk for CVD. Recently, Kitta et al. examined the effect of various
medications used to treat CVD risk factors, along with suggested life-style changes, in
evaluating improvements in brachial artery FMD and predicting future cardiovascular
events (Kitta et al., 2009). Brachial artery FMD was assessed before and after a six month
period that consisted of optimized therapy. At six months, approximately 58% of the
individuals improved their FMD. This change in FMD was seen in the absence of changes
in baseline brachial artery diameter, baseline brachial artery blood flow, increased brachial
artery blood flow, and increased brachial artery diameter after the infusion of NTG (Kitta
et al., 2009). Individuals with an improved FMD had a significantly higher survival rate
without a cardiovascular event during a 36 month follow-up. These findings support the
application of serial FMD measurements as a tool to assess therapeutic options involved in
improving vascular reactivity. While subjects were advised to walk more than 30 minutes
per day, an evaluation to measure adherence to physical activity (PA) was not included,
making it difficult to articulate any benefits of PA in this particular study.
EXERCISE TRAINING AND ENDOTHELIAL FUNCTION
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The beneficial effects of exercise on reducing risk for CVD are well known.
Studies that have assessed the effects of exercise on ED have strengthened decisions to
employ exercise training as an important therapy treatment for ED. As previously
described, increasing shear stress on endothelial cells stimulates secretion of NO leading to
smooth muscle cell relaxation and subsequent vascular dilation. This led investigators to
initially hypothesis that any improvement in ED from exercise would be location specific
due to an increased blood flow to contracting muscles. Kingwell et al. were the first to
demonstrate in humans an enhanced resting NO production in an untrained limb following
4 weeks of cycle training (Kingwell, Sherrard, Jennings, & Dart, 1997). The researchers
suggested that although no muscular adaptations occurred in the unexercised limb, there
were systemic adaptations from exercise, including an increase in pulse pressure that
enhanced the release of NO from non-trained vascular beds. Aside from the 4 week
training study, an exercise session consisting of 30 minute on a cycle was performed to
assess single-arm post-exercise FBF through venous occlusion plethysmography. Forearm
blood flow was significantly increased after a single session of cycle exercise and
remained elevated for approximately 60 minutes after cessation of exercise in a few of the
subjects. This data suggests that regular exercise using a large muscle mass can induce
adaptations in non-exercising limbs, which enhance EF. This important finding justifies
the evaluation of FBF with common aerobic exercise modalities such as cycling and
walking.
As exercise in large muscle groups has been shown to have a systemic effect on the
body, localized training in smaller muscle groups (i.e. forearm) may not be associated with
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systemic effects. Katz et al. examined the effect of exercise training on EF in adults with
idiopathic dilated cardiomyopathy and congestive heart failure symptoms (Katz, Yuen,
Bijou, & LeJemtel, 1997). The subjects performed non-dominant hand grip exercises 30
minutes per day for eight weeks. Peak reactive hyperemic FBF post-training was
significantly increased in the trained arm, but not the untrained arm.
Exercise Training and EF in Subjects with CVD Risks
Many studies have shown an exercise training effect on EF with subjects who were
at higher risk for CVD. Watts et al. evaluated the effect of exercise on EF during eight
weeks of exercise training or eight weeks of non-training (Watts, Beye, Siafarikas,
O'Driscoll et al., 2004). The study recruited obese adolescents who either refrained from
all activity or performed 1 hour sessions of circuit training 3 times per week for eight
weeks. Initially, brachial artery FMD was significantly different in obese versus normal
control subjects. FMD significantly increased in obese adolescents after 8 weeks of
exercise training, which resulted in statistically similar FMD values between obese
adolescents that trained and normal subjects. Woo et al. examined the effect of diet alone
versus diet with exercise on EF in overweight or obese adolescents (Woo et al., 2004).
The diet intervention consisted of a hypocaloric menu that provided 900 – 1200 kcal a day.
The exercise intervention consisted of circuit training exercise 2 times per week for 6
weeks. At the start of the study, overweight adolescents had an impaired brachial artery
FMD compared to a non-obese control group. Although both groups had an improvement
in FMD at the end of the study, the diet and exercise intervention resulted in a significant
improvement in FMD compared to the diet alone. These changes in EF were not seen
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following a sublingual dose of NTG, evidence that the changes in FMD were endotheliumdependent. Additionally, Hamdy et al. examined the effects of EF prior to and following a
6 month diet and exercise intervention in obese adults who had MetS (Hamdy et al., 2003).
The intervention consisted of a diet accounting for 500 kcal per day of negative energy
balance with supervised exercise 3 days per week along with 150 minutes per week of
unsupervised activity. Baseline brachial artery diameter did not change during the
intervention. FMD was significantly improved after the 6 month intervention. As shown
in previously described intervention studies, sublingual administration of NTG did not
result in significant differences in FMD at baseline compared to 6 months.
More recently, Schjerve et al. investigated the effect of various exercise training
modes and intensities on EF in obese individuals (Schjerve et al., 2008). Subjects were
randomized into three groups, which included strength training, moderate-intensity aerobic
training, and high-intensity aerobic training. Participants completed 12 weeks of exercise
training, performing supervised sessions twice per week and one home-based session each
week. Aerobic exercise training was designed to control for caloric expenditure, as the
high-intensity subjects performed 4x4-minute interval bouts at 85 – 95% maximal heart
rate (HRmax) and the moderate-intensity subjects walked for 47 minutes at 60 – 70% of
HRmax (Schjerve et al., 2008). The strength training group performed four sets of 5
repetitions at 90% 1 repetition max on a leg apparatus, in addition to three sets of thirty
repetitions of abdominal and back exercises with a 30 second break between each set.
Brachial artery FMD significantly increased after 12 weeks of training in all three exercise
groups. However, post-training FMD of the high-intensity group was significantly greater
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than the moderate-intensity and strength training group. The moderate-intensity and
strength training group did not have a significantly different post-training FMD. Baseline
brachial artery diameter and blood flow was not significantly different between groups
before training and did not change after 12 weeks of training. Additionally, there was no
significant difference in brachial artery FMD in response to nitroglycerin before or after 12
weeks of training in any of the groups (Schjerve et al., 2008). This study suggests that
aerobic exercise training at high or moderate-intensity and strength training will improve
EF in obese individuals.
Moreover, studies have evaluated other cardiovascular risk factors in determining
the exercise training effect on EF in various populations, such as hypertensives, diabetics,
and hypercholesterolemics (Higashi et al., 1999; Maiorana et al., 2001; Walsh, Yong et al.,
2003). Higashi et al. examined the effect of exercise training on EF in hypertensive
subjects (Higashi et al., 1999). The subjects performed 12 weeks of aerobic exercise,
which consisted of brisk walking (52 ± 9% VO2) for 30 minutes 5 -7 times per week.
After 12-weeks, both systolic and diastolic blood pressures were significantly decreased.
FBF was significantly increased in response to the infusion of acetylcholine at 12 weeks.
This response was abolished with the infusion of NG-monomethyl-L-arginine (L-NMMA),
a known inhibitor of NO. The study proposed that the increased shear stress from increased
flow was responsible for changes in NO production and subsequent increased FBF.
Additionally, investigators have examined the effect of circuit exercise training on
EF in subjects who are diabetic and those who are currently or have previously been
hypercholesterolemic (Maiorana et al., 2001; Walsh, Yong et al., 2003). An 8-week
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training schedule was developed to target the larger muscle groups of the lower body.
Each supervised exercise session lasted one hour, with participants alternating every 45
seconds between seven resistance and eight aerobic exercise stations (Maiorana et al.,
2001). Subjects were required to maintain 70 – 85% of HRmax while at the aerobic stations
and lift 55 – 65% of their baseline maximal voluntary contraction at the resistance stations.
Participants with a history of hypercholesterolemia had one at-home and two supervised
weekly exercise sessions, while those with type 2 diabetes were instructed during three
supervised weekly exercise sessions (Maiorana et al., 2001; Walsh, Yong et al., 2003). At
home, the subjects were encouraged to perform continuous aerobic exercise at 70 – 85% of
HRmax for 45 – 60 minutes. Investigators in both studies measured brachial artery FMD
and FBF before training and then again at the end of the 8 week program. FMD in
response to 5 minutes of forearm ischemia significantly increased after 8 weeks of circuit
training in both subjects with type 2 diabetes and those who had been treated for
hypercholesterolemia (Maiorana et al., 2001; Walsh, Yong et al., 2003). This change
appeared to be endothelium dependent due to a similar non-significant FMD response to
nitroglycerin. FMD did not significantly improve after 8 weeks of circuit training in
untreated hypercholesterolemic subjects (Walsh, Yong et al., 2003). When comparing the
ratio of flow to ACH in the infused arm to flow of the non-infused arm, FBF was
significantly increased following 8 weeks of circuit training in subjects with type 2
diabetes, as well as those who had been treated for hypercholesterolemia (Maiorana et al.,
2001; Walsh, Yong et al., 2003). The increased FBF response to ACH following circuit
training was not observed during the infusion of sodium nitroprusside (SNP), an
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endothelial-independent vasodilator. Likewise, infusion of L-NMMA in subjects who had
been treated for hypercholesterolemia did not result in significant increases in FBF (Walsh,
Yong et al., 2003). Similar to Higashi et al. (1999), both Maiorana et al. (2001) and Walsh
et al. (2003) proposed that the increased endothelial wall shear stress was primarily
responsible for the increase in FMD and FBF following circuit training in subjects with
type 2 diabetes, as well as those who had been treated for hypercholesterolemia.
Interestingly, Green et al. investigated whether EF improvements observed with
exercise resulted from short term repetitive exercise bouts or exercise associated
improvements in CVD risk factor profiles (Green et al., 2003). Eight weeks of circuit
training as described above resulted in an enhanced exercise capacity, emphasized by
significant increases in resting heart rate, maximal exercise test duration, and absolute and
relative VO2peak. Other significant changes that resulted from 8 weeks of circuit training
included an increased muscular strength and decreased peripheral adiposity. Eight weeks
of circuit training did not significantly change plasma lipids, blood pressure, resting blood
glucose, waist-to-hip ratio, or BMI (Green et al., 2003). Brachial artery FMD and FBF, in
response to 5 minutes of forearm ischemia and ACH infusion, respectively, were
significantly increased after 8 weeks of circuit training. Although exercise has been shown
to have a systemic effect on EF, as described above, the study suggests that these changes
in EF are not exclusively related to the effect that exercise has on CVD risk factors. This
further demonstrates the impact exercise training has on the vascular system, with its
frequent, periodic increase in shear stress.
Exercise Training and EF in CVD
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Several studies have evaluated the effect of exercise training on EF in subjects with
cardiovascular disease. Walsh et al. was the first to suggest that individuals with a history
of coronary artery disease had improved EF in the brachial artery following eight weeks of
circuit training as previously described (Walsh et al., 2003; Walsh, Yong et al., 2003). As
demonstrated in other subject populations with impaired EF, brachial artery FMD
significantly increased after eight weeks of exercise training. In keeping with previous
studies described above, brachial artery response to NTG was not significantly different
before versus after exercise.
The effect of aerobic exercise training only on EF in patients with CVD has shown
similar results. Edwards et al. was the first to demonstrate significant improvements in
brachial artery FMD in subjects with coronary artery disease following 12 weeks of
aerobic exercise training (Edwards et al., 2004). Participants exercised 3-times per week
on a treadmill or stationary cycle, progressing intensity and duration, from 40 – 85% of
HRmax reserve and 15 – 50 minutes, respectively. The investigators also reported a
significant increase in plasma nitrate and nitrite levels following 12-weeks of exercise
training, suggesting a plausible mechanism for the improvement in EF (Edwards et al.,
2004). Additionally, as few as four weeks of aerobic exercise training has been shown to
improve EF in patients with CAD (Sixt et al., 2008). Subjects participated in supervised
exercise sessions every day during the first week, followed by three weeks of a daily
home-based exercise routine and supervised training sessions twice per week. Study
findings suggest that relative VO2 significantly improved without a concurrent loss in body
weight after four weeks of exercise training. Subjects who participated in four weeks of
36

exercise training also significantly improved brachial artery FMD, while no difference in
FMD was observed after infusion of NTG (Sixt et al., 2008).
Recently, Vona et al. investigated the effect of varying types of exercise training on
EF in subjects who had recently experienced a myocardial infarction (Vona et al., 2009).
Participants were randomly placed into one of four groups, which consisted of aerobic
training, resistance training, combined training, or a control group. Each group, aside from
the controls, underwent supervised training sessions four times a week for four weeks.
Brachial artery diameter and FMD during reactive hyperemia was not significantly
different between groups at baseline (Vona et al., 2009). After four weeks of training,
brachial artery FMD significantly improved in all four groups, although significantly less
in the control group. The investigators suggested that the increase in FMD observed in the
control group was more likely a secondary response to the maximal exercise test conducted
a day prior. Four weeks of exercise training, independent the mode of exercise appeared to
improve EF in subjects who had recently experienced an uncomplicated myocardial
infarction.
Exercise Training and EF in Healthy Individuals
Although most exercise training studies have evaluated subjects with an increased
risk for CVD disease, a limited number of studies, as described below, have evaluated the
effect of exercise training on EF in healthy subjects. Moreover, these studies are not in
complete agreement that EF is enhanced following exercise training in healthy individuals.
There are several studies that support an enhanced EF following exercise training in
healthy individuals (Clarkson et al., 1999; Goto et al., 2003; Higashi et al., 1999;
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Rakobowchuk et al., 2008). However, there are also studies that suggest that EF is not
significantly enhanced following exercise training and may even be impaired depending
upon the intensity employed during training (Bergholm et al., 1999; Goto et al., 2003;
Rakobowchuk et al., 2005).
Initially, Higashi et al. assessed EF in healthy individuals following 12 weeks of
aerobic exercise consisting of 30 minutes of brisk walking (52 ± 9% VO2max) 5 -7 times per
week (Higashi et al., 1999). Following 12 weeks of exercise, FBF was significantly
increased in response to infused acetylcholine. This increased FBF response was abolished
with the intra-arterial infusion of L-NMMA. Additionally, Clarkson et al. examined the
effect of a 10-week basic military training camp on EF in 35 healthy males (Clarkson et al.,
1999). Following exercise training, baseline vessel diameter of the brachial artery did not
change compared to pre-training diameter size and brachial artery FMD during reactive
hyperemia was significantly increased compared to pre-training values. The authors
suggested that exercise at a reasonable intensity would be beneficial in inducing vascular
change and improving EF. The military recruits performed a daily 3 mile run and
undertook upper-body strength and endurance exercises.
However, in contrast to the previously described studies, one study did not support
an enhanced EF following exercise training. Bergholm et al. evaluated the effect of a highintensity 12-week aerobic exercise study on EF in moderately fit males (BMI 21.8 ± 0.4
kg/m2, VO2max 53 ± 2 ml/kg/min) (Bergholm et al., 1999). The subjects participated in
four, one hour running sessions per week at an intensity that matched 70 – 80% of their
VO2max. FBF in response to ACH significantly decreased after 12 weeks of intense
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exercise training compared to measurements taken before training. FBF in response to
SNP was not significantly different in the subjects before compared to after the exercise
training, suggesting the FBF response to intense exercise training was endotheliumdependent (Bergholm et al., 1999).
The inconsistent findings in exercise training effects on EF in healthy individuals
led Goto et al. to investigate the effect of a 12 week exercise program using different
exercise training intensities on EF (Goto et al., 2003). There were no baseline significant
differences between the three groups who participated in either mild (25% VO2max),
moderate (50% VO2max) or high (75% VO2max) intensity exercise training. Following 12
weeks (30 minutes, 5-7 days each week) of aerobic exercise, only subjects who
participated in moderate intensity exercise had an improvement in FBF following the
infusion of acetylcholine. The infusion of L-NMMA abolished these effects, supporting
the release of NO as the cause for vasodilation. The investigators suggested that the mild
aerobic exercise was not a strong enough stimulus to attain a response, whereas high
intensity aerobic exercise was associated with increasing biomarkers known to decrease
the bioavailability of NO.
Furthermore, Rakobowchuk et al. evaluated the effect of resistance exercise on EF
in 28 healthy young men (Rakobowchuk et al., 2005). The subjects completed a 12 week
progressive protocol, exercising 5 times per week (60 sessions). Brachial artery diameter
and peak FMD during reactive hyperemia significantly increased after 6 weeks of training
and remained elevated at 12 weeks. However, peak and average shear rate in the brachial
artery assessed through a linear array pulse Doppler ultrasound probe were not
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significantly different at any point. When brachial artery FMD was normalized for shear
stimulus, there was no significant FMD change at any time during the training period.
Although EF assessed by FMD did not change during 12 weeks of resistance training, the
findings suggest that resistance exercise could represent a stable adaptation by enhancing
resistance vessel function.
Currently, studies appear to support an improvement in EF in healthy individuals
following moderate-intensity aerobic exercise training. These positive changes in EF with
moderate-intensity training are not well supported in high-intensity aerobic exercise
training or strength exercise training models. Recently, Rakobowchuk et al. compared the
effects of moderate-intensity aerobic training to high-intensity, low-volume, sprint interval
training on EF (Rakobowchuk et al., 2008). The authors suggested that both groups had a
comparable significant improvement in FMD. However, the measurement of FMD was
different than in the studies previously described. Rather than measure FMD in the
brachial artery, the authors measured FMD in the popliteal artery. The FMD response of
the popliteal artery did not measure the systemic effects of the exercise training, rather the
direct effects of a trained limb making it difficult to compare the results of this study to
those previously reported.
In 2008, Heylen et al. described the impact of exercise training frequency on EF in
male Wister rats (Heylen et al., 2008). The study suggested that the thoracic aorta’s
sensitivity to ACH was significantly greater in rats that exercised at a moderate intensity
five days per week, compared to one day per week of moderate PA. The authors provided
evidence that there is a frequency-dependent dose of moderate PA that will elicit
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endothelial-dependent improvements in vascular reactivity. Studies investigating the effect
of exercise frequency training on EF are warranted in human populations, especially those
individuals who are at increased risk for CVD, where exercise training appears to have an
established effect on EF.
ACUTE BOUTS OF EXERCISE AND ENDOTHELIAL FUNCTION
While most studies examine EF following exercise training, EF following acute
exercise has not been extensively researched. Only a few studies have evaluated the effect
of a single bout of exercise on EF in healthy individuals. Initially, Baynard et al. recruited
healthy adult men who were either endurance trained or resistance trained (Baynard,
Miller, & Fernhall, 2003). FBF was measured prior to and immediately after (5 minutes) a
maximal exercise test measuring oxygen consumption. Resting FBF was higher in the
resistance trained group. The endurance trained group had a higher resting reactive
hyperemic FBF. Following maximal exercise, reactive hyperemic FBF declined at slower
levels compared to resting reactive hyperemic FBF in the endurance trained group. The
resistance trained group had significantly higher reactive hyperemic FBF following
exercise compared to resting values. A subsequent study examined FBF in subjects for 2
hours following maximal exercise (Bousquet-Santos, Soares, & Nobrega, 2005). FBF was
measured prior to and 10, 60, and 120 minutes after maximal exercise in 9 healthy adults.
Compared to resting values, baseline FBF was significantly increased at 10 minutes post
exercise, but not 60 and 120 minutes post exercise. Compared to resting values, reactive
hyperemic FBF was significantly increased at 10 and 60 minutes post exercise, but
returned to near baseline numbers at 120 minutes post exercise. It is important to point out
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that this study did not use peak FBF values rather the area under the curve following three
minutes of FBF measurements. These results are very similar to the FBF rate of decline,
which may be controlled by a different mechanism than peak FBF. Finally, Rognmo et al.
recently investigated the effect of a single high-intensity exercise bout on brachial artery
FMD in highly-trained endurance athletes (VO2max 75.9 ± 0.8 mL/kg/min) versus sedentary
controls (VO2max 47.7 ± 1.7 mL/kg/min) (Rognmo et al., 2008). The study consisted of
subjects performing an exercise protocol on the treadmill which included a 15 minute
warm-up (60 – 70% HRmax) and 5 intervals of high-intensity (90% HRmax) running for 3
minutes. During each interval, subjects performed an active recovery (60 – 70% HRmax)
for two minutes. Each subject had brachial artery FMD measured prior to, and 1, 24, and
48 hours post exercise. The authors suggested that baseline FMD was not significantly
different between highly-trained endurance athletes and sedentary, healthy individuals
(Rognmo et al., 2008). FMD measured 1 hour after a single high-intensity exercise bout
was significantly decreased compared to baseline values in highly-trained endurance
athletes and only slightly decreased in the sedentary controls. FMD did not significantly
change in the sedentary control group following exercise and returned to baseline values in
the highly-trained endurance athletes at 24 and 48 hours after exercise. Brachial artery
diameter was significantly larger in the highly-trained endurance athletes compared to the
sedentary controls. However, brachial artery diameter significantly increased 1 hour postexercise compared to baseline diameter measurements in both groups (Rognmo et al.,
2008). Although there was a significant reduction in FMD in the highly-endurance trained
group, the vessel diameter was most likely maximally dilated at 1 hour post-exercise,
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decreasing shear stress and any subsequent vasodilatory effect. The large diameter size
observed in highly-trained endurance athletes is unlike that of individuals with coronary
artery disease. Rather, the decreased FMD after exercise in the highly-trained endurance
group is attributed to an improved “functional” vessel.
Harris et al. was the first to investigate the effects of a single exercise bout on EF in
overweight individuals (Harris, Padilla, Hanlon, Rink, & Wallace, 2008). Subjects were
categorized as either trained or untrained depending on physical activity profiles and
placed randomly in one of three groups, where they walked on a treadmill for 45 minutes
at 25, 50, or 75% of maximal exercise capacity. Brachial artery FMD was assessed prior
to and 1 hour post exercise. Baseline FMD was not significantly different between groups.
Walking 45 minutes at varying exercise intensities did not significantly alter FMD in
trained or untrained overweight individuals (Harris et al., 2008). However, when FMD
was normalized to reflect the absolute response to exercise, trained overweight individuals
significantly improved FMD 1 hour after exercise and untrained overweight individuals
significantly decreased FMD 1 hour after exercise.
Likewise, Umpierre et al. was the first to investigate the effect of sub-maximal
exercise on EF in subjects with chronic heart failure (Umpierre, Stein, Vieira, & Ribeiro,
2009). Subjects performed a single exercise bout for 25 minutes at 10% below a
predetermined, second ventilatory threshold. FBF was measured prior to, immediately
after, 10, 30, 60 minutes, and 24 hours post-exercise. FBF was not significantly different
at baseline between individuals with chronic heart failure and healthy controls. FBF
significantly increased in chronic heart failure subjects in response to exercise immediately
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after and 10 minutes post-exercise before returning back to baseline values at 30 minutes
post-exercise (Umpierre et al., 2009). FBF significantly increased in healthy controls in
response to exercise immediately after, 10, and 30 minutes post-exercise before returning
back to baseline values 60 minutes post-exercise. Interestingly, there were no significant
FBF differences between the two groups when FBF was increased above baseline.
The studies above present important findings in further understanding the effects of
acute exercise on EF. However, an extensive review of literature has produced no study in
which the extended time-course for EF following a single bout of maximal exercise is
shown, especially in obese individuals. As seen later in this review, there are studies that
evaluate an extended time-course of inflammatory biomarkers following exercise that may
have an effect on the EF. This information would be of primary importance, especially
when measuring EF in response to exercise training where maximal exercise tests are
typically performed before and after the training intervention in an attempt to evaluate
changes in maximal exercise capacity. There does not appear to be an established optimal
time before EF is assessed following a training program’s last exercise bout. Previously,
measures have varied between 24 and 72 hours after the final exercise bout.
EXERCISE TRAINING AND ENDOTHELIAL DYSFUNCTION BIOMARKERS
Several studies described below include the measurement of ED biomarkers that
are provoked by exercise training. In a study previously described, Hamdy et al. evaluated
the effects of exercise training on adhesion molecules ICAM-1 and VCAM-1 in subjects
with MetS (Hamdy et al., 2003). Following exercise training, ICAM-1 was significantly
reduced while there was no change in VCAM-1. ICAM-1 is associated with the
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development of atherosclerosis through enhancement of foam cell formation and any
improvement in blood concentration could potentially be linked to a risk reduction in the
development of CVD. Additionally, Niebauer et al. examined the relationship between
eight weeks of exercise training and inflammatory cytokines in subjects with chronic heart
failure (Niebauer, Clark, Webb-Peploe, & Coats, 2005). During the eight weeks, subjects
cycled on a home ergometer for 20 minutes at 70 – 80% of HRmax. The investigators
suggested that there was no effect of exercise training on TNF-α, IL-6, and ICAM-1 in
both subjects with chronic heart failure and age-matched healthy controls (Niebauer et al.,
2005). Furthermore, Stewart et al. examined the influence of exercise training on
inflammatory markers IL-6, TNF-α, and CRP in young and old subjects who were
physically active and inactive, but otherwise healthy (Stewart et al., 2007). The 12 week
training intervention consisted of circuit training performed 3 days per week. When
comparing all groups, there was no significant difference in IL-6 and CRP baseline
concentrations. TNF-α concentration was significantly higher in younger subjects at
baseline, independent of being physically active or inactive. Following exercise training,
the young and old physically inactive had a significant decline in CRP levels. There was
no exercise training effects on TNF-α or IL-6 in any group. Previous findings from Fisher
et al. agreed that no relationship existed between TNF-α levels and PA (Fischer, Berntsen,
Perstrup, Eskildsen, & Pedersen, 2006). However, self-reported qualitative assessments of
PA suggested a significant negative linear association with PA and pro-inflammatory
cytokines, CRP and IL-6 (Fischer et al., 2006).
ACUTE EXERCISE AND ENDOTHELIAL DYSFUNCTION BIOMARKERS
45

Few studies have evaluated the effect of acute exercise on biomarkers associated
with atherosclerosis. Kinugawa et al. examined the effect of maximal exercise on plasma
TNF-α and IL-6 in subjects with CVD (Kinugawa et al., 2003). At baseline, subjects with
CVD had significantly higher levels of plasma TNF-α and IL-6 as compared to healthy
controls. Baseline plasma TNF-α and IL-6 had a significant positive correlation with
norepinephrine levels and a significant negative correlation with VO2peak. Maximal
exercise significantly increased plasma TNF-α and IL-6 in subjects with CVD and healthy
controls. Additionally, von Kanel et al. compared the result of acute exercise on
atherosclerotic risk markers and suggested that mean arterial blood pressure and VO2peak
were independently associated with plasma ICAM-1 and IL-6, respectively (von Kanel,
Hong, Pung, & Mills, 2007). After a 20 minute sub-maximal exercise test on the treadmill,
plasma IL-6 and ICAM-1 were both significantly higher than baseline. However, after 25
minutes post-exercise, plasma ICAM-1 declined to baseline values while IL-6 was
significantly higher than post exercise values. Finally, in a study previously described,
Harris et al. examined the effect of a single bout of exercise at various intensities on
plasma TNF-α and IL-6 levels one hour post-exercise in overweight trained and untrained
men (Harris et al., 2008). The authors suggested that baseline plasma TNF-α was not
significantly different between trained versus untrained overweight men and that exercise
did not significantly alter plasma TNF-α in either group independent of the exercise
intensity. Plasma IL-6 was not significantly different at baseline between trained versus
untrained overweight men. However, both groups had a comparable significant increase in
plasma IL-6 after participating in moderate and high intensity exercise (Harris et al., 2008).
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To date, there are no known studies that evaluate the extended time course of
inflammatory markers after a single bout of exercise. In 2007, a study by Louis et al.
provided evidence that suggests the extended evaluation of inflammatory markers after
exercise may be essential in the understanding of time controlled release of specific
cytokines (Louis, Raue, Yang, Jemiolo, & Trappe, 2007). The extended evaluation of
inflammatory markers may also provide a much better understanding in the evaluation of
vascular reactivity after exercise. Louis et al. investigated the TNF-α mRNA and IL-6
mRNA expression changes following a single aerobic exercise bout, which consisted of
running for 30 minutes on the treadmill at 75% of each subject’s VO2max (Louis et al.,
2007). TNF-α mRNA was significantly elevated immediately after exercise and again 12
and 24 hours after exercise. IL-6 mRNA was significantly elevated immediately after
exercise and again 2, 4, 8, 12, and 24 hours after exercise.
CONCLUSION
The critical effect of endothelial wall activation and its associated role in initiating
atherosclerosis warrants further research of the mediating receptors and circulating agents
that allow for the control of vascular homeostasis. Assessing EF and the biomarkers
associated with its control is vital in understanding interventions that may help not only
slow the progression of CVD but negate specific CVD risk factors. The underlying
mechanisms that control EF changes following exercise training have received a large
amount of attention and continue to be evaluated. PA has been shown as an important
mediator for improving EF through the generation of shear stress. Current research
supports the importance of NO on vasodilation and previous studies agree with the role
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shear stress plays in stimulating NO release from endothelial cells, contributing to the
increased vascular blood flow during exercise. Technical considerations in the assessment
of exercise induced alterations of EF are beneficial in contributing to the proposed
mechanisms of adaptation.
Direct non-invasive tools used to assess EF include high resolution vascular
ultrasonography and venous occlusion strain-gauge plethysmography. These tools allow
researchers to mimic the shear stress which is often associated with exercise. Inflatable
cuffs wrapped around the upper arm and wrist allow for control of blood flow in the
forearm. Turbulent shear stress can be generated following a brief period of ischemia due
to cuff inflation. The reactive hyperemia has been closely associated with NO availability
and the change from baseline in FBF and FMD are directly related to EF.
During the assessment of EF, an intra-arterial catheter can be used to infuse
different agents such as acetylcholine and L-NMMA. Sublingual doses of nitroglycerin
are also commonly used during the assessment of EF. These agents have helped
researchers characterize the role of endothelial cells in mediating vascular relaxation and
have strengthened the role NO has on EF. Unfortunately, many laboratories do not have
the means, for various reasons, to access these clinical drugs. This emphasizes the
importance in understanding various mechanisms that control for NO availability.
Biomarkers, such as TNFα, IL-6, ET, and CRP, can be easily measured and are suggested
to be directly involved in the regulation of NO availability.
Myokines, known as cytokines released from skeletal muscle, are generally
secreted in response to PA. Although several cytokines will soon be acknowledged as
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myokines, only one cytokine has been recognized as a myokine. IL-6 is known to have
numerous secretion sites, including adipose and skeletal tissue. Acute exercise studies
support the role of cytokines released from areas other than adipose tissue and as described
in this review, it is proposed that myokines may have different functional roles than
adipokines. Myokines may help support the well understood mechanics of glucose
homeostasis during exercise and increased blood flow to contracting muscles in need of
more oxygen.
Future research directions include an extended time course of acute exerciseinduced adaptation on EF. The time course of exercise induced adaptations on EF has
been evaluated in only a few studies giving rise to the need for a similar study in healthy
and obese subjects. Exercise training study results are inconclusive as to whether the
exercise interventions improve EF or whether improvements in EF are simply a reflection
of the alterations from the last exercise bout performed. A study designed to address this
issue would be beneficial in establishing an optimal time point to assess EF following an
exercise training program. Findings may also allow researchers to further understand the
impact an acute exercise bout can have on regulating the vasodilatory capacity of the
arterial wall.
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THE EXTENDED TIME COURSE OF FOREARM BLOOD FLOW
FOLLOWING A SINGLE MAXIMAL BOUT OF EXERCISE
Abstract
Chronic exercise is thought to improve endothelium-dependent vasodilation;
however, studies evaluating endothelial dysfunction (ED) following an exercise training
program lack a standardized time frame in which to measure vascular function (VF).
Although most studies require subjects to abstain from exercise for 24 hours prior to any
VF measures, no study to date has assessed VF longer than 24 hours after the cessation of
exercise. Purpose: To evaluate VF, as determined by the assessment of forearm blood
flow (FBF) and vascular reactivity (VR) before and up to 48 hours after a single bout of
maximal exercise in healthy male volunteers. Methods: Twelve male subjects volunteered
to participate. FBF was assessed before and during reactive hyperemia (RH). FBF
measures were obtained prior to (PRE-E), immediately after (POST-E), and at 1 (POST-1),
2 (POST-2), 24 (POST-24), and 48 (POST-48) hours after exercise. Total excess flow,
calculated as the difference between baseline FBF and FBF during RH, was used as an
indicator of VR. Blood samples were also obtained at each time point to evaluate the
response of interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-α), which are
potential modifiers of VF. Results: Baseline FBF and FBF during RH were significantly
(P < 0.05) increased POST-E before returning to baseline values by POST-1. VR was
significantly (P < 0.05) increased POST-E and was not significantly (P < 0.05) reduced
until POST-48. Concentrations of IL-6 and TNF-α were unchanged in response to
exercise. Conclusions: These results suggest that measurements used to verify
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improvements in VF following exercise training should be employed after a minimum of
48 hours following physical activity.
Introduction
In healthy individuals, the quiescent state of the vascular system is maintained by
vasoactive compounds produced by endothelial cells. These compounds are responsible
for cellular adhesion, thromboresistance, smooth muscle cell proliferation, vessel wall
inflammation, and most importantly, modulating vascular tone (5). Reduced endotheliumdependent vasodilation, also known as endothelial dysfunction (ED), is associated with the
early sub-clinical stages of atherosclerosis and often the result of a decreased nitric oxide
(NO) bioavailabity (12, 18). Several inflammatory bio-markers, including tumor necrosis
factor-α (TNF-α) and interleukin-6 (IL-6), are directly related to NO bioavailability and
subsequently, vascular function (VF) (14, 15, 22). TNF-α has been shown to inhibit NO
release from endothelial cells and degrade nitric oxide synthase mRNA, which can lead to
an impairment of endothelium-dependent vasodilation (15, 22). The role of IL-6 has
recently received renewed attention as its origin of secretion is now thought to determine
its function. Whereas IL-6 released from adipose tissue is associated with an increase in
the pro-inflammatory marker C-reactive protein (15), IL-6 secreted from contracting
skeletal muscle is associated with the stimulation of anti-inflammatory cytokines and
inhibition of TNF-α (14). Furthermore, exercise training studies do not support a change
in resting TNF-α or IL-6 concentrations (13, 19).
TNF-α and IL-6 concentrations have been shown to significantly increase
immediately following acute exercise in healthy individuals, as well as those with
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inflammatory disease (10). However, there are no studies that evaluate the extended time
course of inflammatory markers after a single bout of exercise. Louis and colleagues
recently demonstrated that TNF-α mRNA in muscle was significantly elevated
immediately after acute exercise, as well as at 12 and 24 hours post-exercise (11).
Likewise, IL-6 mRNA in muscle was significantly elevated immediately after acute
exercise, and at 2, 4, 8, 12, and 24 hours post-exercise. An extended evaluation of
inflammatory markers after acute exercise may contribute to a further understanding of the
mechanisms influencing changes in VF following exercise.
Chronic aerobic exercise training is thought to improve ED with much of the
improvement in the vasodilatory capacity being attributed to the effects of an increase in
exercise-induced shear stress production of NO (7, 8, 21). However, studies evaluating ED
following an exercise training program lack a standardized time frame in which to measure
VF following the final training bout. There are no studies that have included a specified
amount of time after training to measure VF, with most reporting an abstinence of exercise
for 24 hours (6-8, 17, 21, 23).
Few studies have evaluated the effect of acute exercise on VF. Bousquet-Santos
and colleagues evaluated VF by measuring forearm blood flow (FBF) and vascular
reactivity (VR) in healthy sedentary volunteers for two hours following a maximal exercise
bout (4). VR, calculated as the excess blood flow following a 5 minute bout of ischemia,
was significantly elevated immediately after exercise and remained elevated for an hour,
before returning to baseline within two hours of exercise. Likewise, Umpierre and
colleagues measured FBF in stable chronic heart failure (CHF) patients and healthy
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controls up to 24 hours after a sub-maximal exercise bout (20). Although no significant
differences in FBF were seen between the groups across time, the FBF in CHF patients and
healthy volunteers were back to baseline within 30 and 60 minutes, respectively.
Neither of the aforementioned studies that evaluated FBF after exercise assessed
inflammatory markers, which as previously stated, may affect prolonged post-exercise
FBF measures. Therefore, the purpose of this study was to evaluate an extended time
course of FBF and vascular reactivity (VR) changes following a maximal aerobic bout of
exercise for up to 48 hours. Additionally, we aimed to evaluate the changes in blood
markers associated with vascular endothelium activation following maximal exercise to
further understand possible contributions to FBF response.
Methods
Subjects
Thirteen apparently healthy male subjects between the ages of 20 and 25 years
volunteered to participate in this study. Subjects were excluded if they were smokers, had
been diagnosed with diabetes or high blood pressure, had any form of known
cardiovascular disease, or were taking medications that would potentially affect vascular
function. Subjects were also excluded if they were participating in high levels of physical
activity as determined by the International Physical Activity Questionnaire at the time of
the study. Subjects were instructed to refrain from exercise for 3 days prior to the start of
the study and during the course of the study. Subjects were also instructed to refrain from
alcohol and caffeine for 24 hours prior to testing and during the 3 days of testing. Written
informed consent was obtained from each subject before participation in the study. All
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procedures were approved by Virginia Commonwealth University’s Institutional Review
Board.
Study Design
Subjects were instructed to report to the Human Performance Laboratory at 6:30
a.m. following an overnight fast. Subjects completed a medical history questionnaire and
physical activity readiness questionnaire (PAR-Q) prior to the start of testing.
Additionally, a physical activity diary was employed during the course of the study to
evaluate physical activity outside of the study protocol. After a 30-min rest period, a 7 ml
blood sample was obtained from an anticubital vein. Body composition was assessed with
dual-energy x-ray absorptiometry (DXA; Lunar iDXA, GE Healthcare, Madison, WI).
Resting heart rate (HR), blood pressure (BP), and FBF measures were taken prior (PRE-E)
to the maximal exercise test. Blood samples and subsequent BP and FBF measures were
taken immediately after exercise (POST-E) and 1 (POST-1), 2 (POST-2), 24 (POST-24),
and 48 (POST-48) hours after the cessation of exercise. All FBF measures were taken on
the right arm, opposite of all blood sampling. All subjects were asked to remain in the
laboratory until after the 2 hour post-exercise measurements. On days 2 and 3, subjects
reported to the laboratory following an overnight fast 30 minutes prior to times
corresponding to 24 and 48 hours after the cessation of exercise, respectively. A blood
sample, BP, and FBF were taken following a 30-minute rest period.
Maximal Exercise Protocol
Each subject was fitted with a heart rate monitor and respiratory gas analysis
equipment (VMAX Spectra, Sensormedics Corp., Yorba Linda, CA) before completing a
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graded exercise test to exhaustion on a treadmill. Following a 3-minute warm-up period,
the treadmill speed was increased to elicit 80% of each individual’s age-predicted maximal
heart rate within 4 minutes. Thereafter, grade was increased by 2% every 2 minutes until
the subject could no longer maintain the treadmill pace. The protocol was designed to last
8 – 12 minutes. Heart rate was obtained every minute and rating of perceived exertion
(RPE) was obtained once every exercise stage. Following an immediate blood pressure
measurement, a 1-minute post-exercise capillary blood lactate sample (Lactate Scout,
Sports Resource Group, Inc.) was obtained and used as a partial criterion to ensure that the
subject gave a maximal effort. Breath-by-breath oxygen consumption was averaged every
10 seconds and the highest averaged value was identified as the maximal oxygen
consumption (VO2max).
Forearm Blood Flow Measurement
Forearm blood flow (FBF) was assessed using mercury-in-rubber strain-gauge
plethysmography (MSGP; Model AI6, D.E. Hokanson, Inc., Bellevue, WA). Blood
pressure cuffs were positioned around each subject’s upper right arm and right wrist, and a
mercury-in-rubber strain gauge was placed around the forearm approximately 10 cm distal
to the olecranon process (1). During each trial, the wrist cuff was inflated to a pressure of
240 mmHg prior to each measurement to occlude hand circulation. Baseline FBF was
determined by rapidly inflating the upper cuff to 40 mmHg for 10 seconds to occlude
venous flow during a 20 second cycle. Nine measurements were recorded to determine the
average rate of volume change during venous occlusion (ml/100 ml of forearm tissue
volume/min). Subsequently, the upper arm cuff was inflated to 240 mmHg to induce
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forearm ischemia for a period of 5 minutes. After 5 minutes of occlusion, the cuff was
released and FBF, as described above, was determined during a 3-minute period of reactive
hyperemia (RH). Total FBF, both at baseline and during RH were assessed as an area
under the curve (AUC), calculated as a flow-time index. Vascular reactivity (VR),
indicated by total excess blood flow above baseline, was calculated as total FBF during RH
minus total FBF at baseline.
Biochemical Analyses
Blood samples for analysis of TNF-α and IL-6 were collected into serum separator
tubes and allowed to clot for 30 minutes before being centrifuged for 15 minutes at ~1000
x g. Serum was immediately aliquoted into microtubes and stored at -80°C until analyzed.
Concentrations of TNF-α and IL-6 were determined through enzyme high-sensitivity
immunoassay according to manufacturer’s specifications (R&D Systems, Minneapolis,
MN). All samples were run in duplicate and the mean concentration of each sample was
used in statistical analysis.
Statistical Analyses
A one-way ANOVA (SPSS, Chicago, IL: V17.0) was used to determine the impact
of a maximal exercise test on FBF, VR, and serum cytokine (IL-6 and TNF-α)
concentration changes across six different time periods (PRE-E, POST-E, POST-1, POST2, POST-24, and POST-48). When indicated by a significant F-ratio, a Bonferroni posthoc analysis was performed to identify differences. Additionally, Pearson productmoment correlations were utilized to evaluate relationships among cardiorespiratory fitness
values, vascular function, and cytokine (IL-6 and TNF-α) responses following the maximal
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effort. Descriptive statistics were used to illustrate subject demographics and exerciseinduced physiological variables to the maximal bout of exercise. All data are expressed as
mean ± SEM unless otherwise noted. Statistical significance was set at P < 0.05.
Results
Subject Characteristics and physiological responses to acute maximal exercise
Of the thirteen subjects that volunteered for this study, one individual requested to
withdraw from the study due to an aversion to the blood sampling procedures. Therefore,
12 subjects were used in the final analyses. Subject characteristics are presented in Table
1. Table 2 provides the physiological responses to the maximal exercise test. The total
duration of the maximal exercise test did not include the warm-up. One volunteer had
difficulty breathing through the respiratory gas sensor and had the flow sensor removed
during the maximal exercise test, however the subject continued with the protocol until
expressing volitional fatigue. Therefore, 11 subjects were used for all VO2max data
analyses.
FBF in response to acute maximal exercise
The AUC for FBF at baseline and during RH are shown in Figures 1 and 2,
respectively. A one-way ANOVA revealed a significant F-ratio for FBF, both at baseline
and during RH, across time (P = 0.0001 and P = 0.001, respectively). A Bonferroni posthoc analysis revealed that FBF, at baseline and during RH, was significantly (P < 0.0001)
elevated POST-E compared to PRE-E, before returning to baseline values within POST-1
(P < 0.01, POST-E vs. POST-1). FBF, at baseline and during RH, remained at values
similar to PRE-E at POST-2, POST-24, and POST-48. VR, expressed as total excess
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blood flow, is shown in Figure 3. A one-way ANOVA revealed a significant (P = 0.014)
F-ratio for VR across time. Furthermore, a Bonferroni post-hoc analysis revealed that VR
was significantly elevated (P = 0.017) POST-E compared to PRE-E. VR remained
elevated, although not significantly different from PRE-E, at POST-1, POST-2, and POST24 before returning to values at POST-48 significantly (P = 0.044) lower than POST-E.
Moreover, VR PRE-E was not significantly correlated to VO2max per lean muscle
mass (r = 0.348, P = 0.295). However, VR PRE-E was significantly correlated to BMI (r =
.749, P = 0.005), fat mass (r = 0.812, P = 0.001), and percent fat (r = 0.651, P = 0.022).
IL-6 and TNF-α response to acute maximal exercise
Figure 4 illustrates the IL-6 and TNF-α response to acute maximal exercise. A oneway ANOVA revealed that IL-6 and TNF-α were not significantly different across time (P
= 0.173 and P = 0.653, respectively). Additionally, IL-6 and TNF-α were not significantly
correlated to VR across time (r = 0.050, P = 0.678 and r = 0.172, P = 0.158, respectively).
The mean coefficient of variation for all IL-6 and TNF-α samples run was 17.98 ± 2.00%
and 10.94 ± 1.03, respectively.
Discussion
This is the first study that has evaluated FBF and VR at time points up to 48 hours
after a single maximal bout of aerobic exercise. The main finding of this study was that
VR following a single maximal bout of aerobic exercise was not significantly reduced
from the immediate post-exercise measure until 48 hours after the cessation of exercise.
FBF and FBF during RH significantly increased immediately after exercise, before
returning to pre-exercise levels within 1 hour of exercise. Additionally, IL-6 and TNF-α
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did not significantly change from baseline values for the duration of this study. However,
IL-6 did increase up to 2 hours following exercise, before decreasing below pre-exercise
concentrations.
Similar to other studies measuring FBF and VR following an acute aerobic exercise
bout, our study did show an increase in FBF and VR immediately following exercise (2-4,
9). Kingwell and colleagues demonstrated an increase in FBF immediately following 30
minutes of cycling at 65% of VO2max in healthy individuals (9). However, it is unclear
how long the increase in FBF lasted after exercise, as the investigators only presented
results from three subjects who continued to have an increased FBF at 60 minutes post
exercise. FBF and VR have been measured after a maximal exercise test in only two other
studies. Bousquet-Santos and colleagues demonstrated a significant increase in FBF
during RH and VR immediately following a maximal exercise test in healthy sedentary
individuals (4). The increase in FBF during RH and VR were still significantly elevated at
1 hour post exercise before returning to baseline levels within 2 hours post exercise. It is
important to note that our healthy males had a greater cardiorespiratory fitness level,
demonstrated by a greater relative VO2max (50.9 ± 1.1 vs. 44.8 ± 2.1, mlO2/kg/min), than
those previously reported. Rognmo and colleagues speculated that lower fitness levels
were often associated with smaller arteries that may have a greater vascular dilation
response due to an increased hyperemic shear stress (16). The previously reported FBF
during RH and VR that was significantly increased 1 hour after maximal exercise may
have been attributed to a subject population with smaller arteries and a subsequent greater
hyperemic shear stress. Baynard and colleagues evaluated the difference in FBF during
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RH in resistance trained versus endurance trained men following a maximal exercise test
(2, 3). FBF during RH was significantly elevated immediately after exercise in resistance
and endurance trained individuals.
IL-6 and TNF-α were not significantly different at any time point up to 48 hours
following a maximal bout of aerobic exercise. This finding is in contrast to previous
reports that have demonstrated a significant increase in IL-6 and TNF-α following a
maximal bout of exercise (10). Additionally, Louis and colleagues recently suggested that
the concentration of IL-6 and TNF-α mRNA cytokine release in response to exercise
varied significantly up to 48 hours post-exercise (11). An acute sub-maximal bout of
aerobic exercise significantly increased IL-6 mRNA immediately and 4, 8, 12 and 24 hours
post-exercise. TNF-α mRNA demonstrated a temporal response to exercise as well with
significant increases immediately and 2, 12, and 24 hours following an acute sub-maximal
bout of aerobic exercise. Louis and colleagues did not determine the functional protein
expression translated from the increased mRNA markers following acute aerobic exercise.
Any change in IL-6 and TNF-α during an extended time-course following exercise could
affect endothelium-dependent vasodilation. However, the IL-6 and TNF-α responses to
acute exercise in the current study suggest that FBF and VR at rest and following a single
maximal aerobic bout of exercise are independent of the response of these blood markers
in healthy males.
These results must be viewed within the context of this study’s limitations. We did
not measure the size of the arteries in the forearm under investigation, therefore can not
conclude that variation in shear stress was responsible for differences seen in our study
61

compared to results previously reported. It is also important to note that we did not take a
sample of blood between our immediate post-exercise measure and 1 hour after exercise
and are unable to conclude that a shortened inflammatory response did not occur within
our measurement period. Additionally, if the functional protein expression of IL-6 and
TNF-α varied following exercise in a similar response to the mRNA expression previously
indicated, then measurement time becomes crucial in determining a change in biomarker
activity. Lastly, although the sample size for this study is small, it is in accordance with
other studies investigating this area of research (2-4, 16, 20).
In conclusion, a single maximal bout of aerobic exercise resulted in an immediate
increased VR that did not significantly reduce from the immediate post-exercise value until
48 hours after exercise. Additionally, FBF at baseline and during RH significantly
increased immediately after exercise before falling to pre-exercise values within 1 hour.
These changes in FBF and VR following exercise demonstrate that although healthy males
have an increased vascular conductance immediately after exercise, they also have a
significantly enhanced reactive vasodilation immediately following exercise. Although
VR at 1, 2, 24, and 48 hours after exercise were not significantly different from preexercise values, these results suggest that any increase observed in VR up to 24 hours after
exercise may be directly due to the previous exercise bout. We did not measure VR
between 24 and 48 hours and can not speculate any changes that may have occurred
between those two measurement periods. Exercise training studies that may use VR as an
assessment of vascular improvements following exercise need to be cautious in taking pre
and post measurements at different times of the day due to any diurnal variations that could
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exist. Therefore, although further research is necessary to understand VF following a
single maximal bout of aerobic exercise, this study recommends that any measurement
used to assertively elucidate improvements in VF following exercise training should be
performed at least 48 hours after the last exercise session. IL-6 and TNF-α did not change
in response to a single maximal bout of exercise and do not support the changes seen in
FBF following the exercise session. Future studies are warranted that investigate the acute
extended time course effects of various exercise intensities and VR measurement times in
healthy individuals.
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Table 1

Subject characteristics, N = 12

Variable

Mean ± SEM

Age (years)

21.6 ± 0.4

Weight (kg)

67.8 ± 2.8

BMI (kg/m2)

21.9 ± 0.3

Percent Fat (%)

19.8 ± 1.4

Fat Mass (kg)

13.0 ± 1.2

Lean Mass (kg)

51.9 ± 1.9

Resting HR (bpm)

56.0 ± 2.2

Resting SBP (mm Hg)

119.3 ± 4.2

Resting DBP (mm Hg)

66.6 ± 2.1

Baseline TNF-α (pg/mL)

1.2 ± 0.1

Baseline IL-6 (pg/mL)

1.3 ± 0.5

BMI, Body Mass Index; HR, Heart Rate; SBP, Systolic Blood Pressure; DBP, Diastolic
Blood Pressure; TNF-α, Tumor Necrosis Factor – alpha; IL, Interleukin.
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Table 2

Physiological responses to acute maximal exercise, N = 12

Variable

Mean ± SEM

Maximal Lactate (mmol/L)

10.6 ± 0.7

Maximal RPE

19.5 ± 0.1

Maximal HR (bpm)

195.9 ± 2.3

Testing Time (s)

709.9 ± 33.6

Relative VO2max (mLO2/BM/min)

50.9 ± 1.1

Relative VO2max (mLO2/LM/min)

66.1 ± 1.2

Absolute VO2max (LO2/min)

3.4 ± 0.1

RPE, Rating of Perceived Exertion; HR, Heart Rate; VO2max, Maximal Oxygen
Consumption; BM, Body Mass (kg); LM, Lean Mass (kg).
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Figure 1. Forearm blood flow during baseline calculated as the area under the curve
(mean ± SEM). *p<0.05 vs. PRE-E, †p<0.05 vs. POST-E.
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Figure 2. Forearm blood flow during reactive hyperemia calculated as the area under the
curve (mean ± SEM). *p<0.05 vs. PRE-E, †p<0.05 vs. POST-E.
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Figure 3. Vascular reactivity, calculated as total RH FBF minus total baseline FBF (mean
± SEM). *p<0.05 vs. PRE-E, †p<0.05 vs. POST-E.
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Figure 4. The effect of acute maximal exercise on serum concentrations of IL-6 and TNFα (mean ± SEM).
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FOREARM BLOOD FLOW RESPONSE TO AN ACUTE MAXIMAL EXERCISE
BOUT IN OBESE AND NORMAL WEIGHT MALES
Abstract
One of the earliest sub-clinical stages associated with atherosclerosis is endothelial
dysfunction (ED), which has been shown to predict future cardiovascular events. Chronic
exercise is thought to improve endothelium-dependent vasodilation; however, few studies
have evaluated the effects of acute exercise on vascular function (VF). In addition, no
studies have compared VF responses in obese and non-obese individuals following acute
exercise. Purpose: To evaluate VF, as determined by the assessment of forearm blood
flow (FBF) and vascular reactivity (VR) before and up to 48 hours after a single bout of
maximal exercise in obese and non-obese males. Methods: Twelve obese (37.0 ± 1.1
kg/m2) and twelve non-obese (21.9 ± 0.3 kg/m2) males volunteered to participate. FBF
was assessed before and during reactive hyperemia (RH). FBF measures were obtained
prior to (PRE-E), immediately after (POST-E), and at 1 (POST-1), 2 (POST-2), 24 (POST24), and 48 (POST-48) hours after exercise. Total excess flow, calculated as the difference
between baseline FBF and FBF during RH, was used as an indicator of VR. Blood
samples were also obtained to evaluate the response of interleukin-6 (IL-6) and tumor
necrosis factor alpha (TNF-α), which are potential modifiers of VF. Results: Baseline
FBF and FBF during RH were significantly (P < 0.05) increased in both groups POST-E
before returning to baseline values by POST-1. VR was enhanced in both groups POST-E,
although the magnitude of change was significantly greater in non-obese males.
Concentrations of IL-6 and TNF-α were unchanged in response to exercise in both groups.
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Conclusions: An acute bout of maximal exercise significantly increased forearm
endothelium-dependent vasodilation in non-obese and obese males. Additionally, an
increased reactive vasodilation was observed only in non-obese males following exercise.
Introduction
The most recent prevalence report of overweight and obesity in the United States
estimates that the incidence of obesity has continued to rise, as 32.2% of all individuals
over the age of 20 years are classified as obese (21). This is particularly alarming given
that obesity is widely considered an independent risk factor for cardiovascular disease
(CVD) (23). Atherosclerosis, a group of diseases distinguished by arterial wall thickening,
accounts for approximately three-fourths of all CVD deaths (27). Additionally,
atherosclerosis is a progressive condition where pathological changes will occur many
years earlier in arteries prior to the onset of adult clinical symptoms. One of the earliest
sub-clinical stages in the atherosclerotic process is the impairment of endotheliumdependent vasodilation, also known as endothelial dysfunction (ED) (29). ED can be
detected prior to the development of atherosclerotic plaques in both coronary and
peripheral vessels and has been associated with the pathogenesis of numerous CVD risk
factors (7). The assessment of vascular function can therefore be useful in detecting the
onset of atherosclerosis, quantifying cardiovascular risk, and determining the effectiveness
of intervention programs (14, 38).
The endothelium is a dynamic paracrine organ made up of a single layer of cells
and found between the lumen and the smooth muscle cells of blood vessels. This layer of
cells respond to physical and chemical signals by secreting factors that regulate vascular
75

tone, cellular adhesion, cell migration and proliferation, and vascular inflammation (6, 7).
In healthy individuals, the quiescent state of the vascular system is maintained by
vasoactive compounds released by endothelial cells, most notably nitric oxide (NO).
Vascular shear stress that accompanies increased blood flow during exercise has been
shown to stimulate the release of NO (20). Chronic aerobic exercise training is known to
decrease CVD risks and numerous studies have shown that vascular function improves
with recurring bouts of aerobic exercise in both healthy individuals and those at higher risk
of CVD (5, 10, 12, 13, 19, 28, 34, 36, 39). Moreover, the improvement in vascular
function following aerobic exercise training appears to be independent of any simultaneous
improvement in CVD risk factors (11).
Research supports the potential role of systemic inflammation in the
pathophysiology of ED (4, 8, 17, 18, 22, 24, 35). Obesity is characterized as a state of
chronic low-grade inflammation and several circulating inflammatory markers, including
tumor necrosis factor-α (TNF-α) and interleukin-6 (IL-6), are directly related to adiposity
(4, 8, 17). TNF-α has been shown to inhibit NO release from endothelial cells and degrade
nitric oxide synthase mRNA, which can lead to an impairment of endothelium-dependent
vasodilation (24, 35). The role of IL-6 has recently received renewed attention as its origin
of secretion is now thought to determine its function. Whereas IL-6 released from adipose
tissue is associated with an increase in the pro-inflammatory marker of C reactive protein
(24), IL-6 secreted from contracting skeletal muscle is associated with the stimulation of
anti-inflammatory cytokines and inhibition of TNF-α (22). Although no studies have
evaluated the extended time course of IL-6 and TNF-α following exercise, Louis and
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colleagues demonstrated increased IL-6 and TNF-α mRNA changes in skeletal muscle up
to 24 hours following an acute bout of exercise (18).
Few studies have evaluated the effect of acute exercise on vascular function.
Bousquet-Santos and colleagues measured forearm blood flow (FBF) and vascular
reactivity (VR) in healthy sedentary volunteers for two hours following a maximal exercise
bout (3). VR was significantly elevated immediately after exercise and remained elevated
for an hour before returning to baseline within two hours of exercise. Likewise, Umpierre
and colleagues measured FBF in stable chronic heart failure (CHF) patients and healthy
controls up to 24 hours after a sub-maximal exercise bout (31). No significant differences
in FBF were observed between the groups across time and FBF had returned to baseline in
both groups within one hour.
The extended response of FBF and VR to maximal exercise in obese individuals
has not been evaluated. Therefore, the purpose of this study was to evaluate the FBF and
VR changes in obese and non-obese males following a maximal aerobic exercise bout.
Additionally, we evaluated the changes in blood markers associated with vascular
endothelium activation following maximal exercise in both groups.
Methods
Subjects
Twenty five male subjects between the ages of 19 and 29 years volunteered to
participate in this study. Subjects were categorized by their BMI into either a non-obese (n
= 13, BMI ≤ 25 kg/m2) or obese (n = 12, BMI ≥ 30 kg/m2) group. Subjects were excluded
from the study if they were smokers, had been diagnosed with diabetes or high blood
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pressure, had any form of known cardiovascular disease, or were taking medications that
would potentially affect vascular function. Subjects were also excluded if they were
participating in high levels of physical activity as determined by the International Physical
Activity Questionnaire at the time of the study. Subjects were instructed to refrain from
exercise for 3 days prior and alcohol and caffeine for 24 hour prior to the start of the study
and during the course of the study. Written informed consent was obtained from each
subject before participation in the study. All procedures were approved by Virginia
Commonwealth University’s Institutional Review Board.
Study Design
Subjects were instructed to report to the Human Performance Laboratory at 6:30
a.m. following an overnight fast. Subjects completed a medical history questionnaire and
physical activity readiness questionnaire (PAR-Q) prior to the start of testing.
Additionally, a physical activity diary was employed to evaluate physical activity outside
of the study protocol. After a 30-min rest period, a 7 ml blood sample was obtained from
an anticubital vein. Body composition was assessed with dual-energy x-ray
absorptiometry (DXA; Lunar iDXA, GE Healthcare, Madison, WI). Resting heart rate
(HR), blood pressure (BP), and FBF measures were taken prior (PRE-E) to the maximal
exercise test. Blood samples and subsequent BP and FBF measures were taken
immediately after exercise (POST-E) and 1 (POST-1), 2 (POST-2), 24 (POST-24), and 48
(POST-48) hours after the cessation of exercise. All FBF measures were taken on the right
arm, opposite of all blood sampling. All subjects were asked to remain in the laboratory
until after the 2 hour post-exercise measurements. On days 2 and 3, subjects reported to
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the laboratory, following an overnight fast, 30 minutes prior to times corresponding to 24
and 48 hours after the cessation of exercise, respectively. A blood sample, BP, and FBF
were taken following a 30-minute rest period.
Maximal Exercise Protocol
Each subject was fitted with a heart rate monitor and respiratory gas analysis
equipment (VMAX Spectra, Sensormedics Corp., Yorba Linda, CA) before completing a
graded exercise test to exhaustion on a treadmill. Following a 3-minute warm-up period,
the treadmill speed was increased to elicit 80% of each individual’s age-predicted maximal
heart rate within 4 minutes. Thereafter, grade was increased by 2% every 2 minutes until
the subject could no longer maintain the treadmill pace. The protocol was designed to last
8 – 12 minutes. Heart rate was obtained every minute and rating of perceived exertion
(RPE) was obtained once every exercise stage. Following an immediate blood pressure
measurement, a 1-minute post-exercise capillary blood lactate sample (Lactate Scout,
Sports Resource Group, Inc) was obtained and used as a partial criterion to ensure that the
subject gave a maximal effort. Breath-by-breath oxygen consumption was averaged every
10 seconds and the highest averaged value was identified as the maximal oxygen
consumption (VO2max).
Forearm Blood Flow Measurement
Forearm blood flow (FBF) was assessed using mercury in-rubber strain gauge
plethysmography (MSGP; Model AI6, D.E. Hokanson, Inc., Bellevue, WA). Blood
pressure cuffs were positioned around each subject’s upper right arm and right wrist, and a
mercury-in-rubber strain gauge was placed around the forearm approximately 10 cm distal
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to the olecranon process (1). During each trial, the wrist cuff was inflated to a pressure of
240 mmHg prior to each measurement to occlude hand circulation. Baseline FBF was
determined by rapidly inflating the upper cuff to 40 mmHg for 10 seconds to occlude
venous flow during a 20 second cycle. Nine measurements were recorded to determine the
average rate of volume change during venous occlusion (ml/100 ml of forearm tissue
volume/min). Subsequently, the upper arm cuff was inflated to 240 mmHg to induce
forearm ischemia for a period of 5 minutes. After 5 minutes of occlusion, the cuff was
released and FBF, as described above, was determined during a 3-minute period of reactive
hyperemia (RH). Area under the curve (AUC), calculated as a flow-time index, provided
values for total FBF both at baseline and during RH. Vascular reactivity (VR), indicated
by total excess blood flow above baseline, was calculated as total FBF during RH minus
total FBF at baseline.
Biochemical Analyses
Blood samples for analysis of TNF-α and IL-6 were collected into serum separator
tubes and allowed to clot for 30 minutes before being centrifuged for 15 minutes at 1000 x
g. Serum was immediately aliquoted into microtubes and stored at -80°C until analyzed.
Concentrations of tumor necrosis factor-α and interleukin-6 were determined through
enzyme high-sensitivity immunoassay according to manufacturer’s specifications (R&D
Systems, Minneapolis, MN). All samples were analyzed in duplicate and the mean
concentration of each sample was used during the statistical analysis.
Statistical Analysis
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A mixed between-within repeated measures (RM) ANOVA (SPSS, Chicago, IL:
V16.0) was used to determine the impact of a maximal exercise bout on systolic blood
pressure (SBP), FBF, VR, and serum cytokine (IL-6 and TNF-α) concentration changes
between the two groups (non-obese and obese males) across six different time periods
(PRE-E, POST-E, POST-1, POST-2, POST-24, and POST-48). If a main effect was
observed within groups, a one-way ANOVA was used to determine differences across
time, with a Bonferroni post-hoc analysis being performed to identify differences.
Additionally, Pearson product-moment correlations were utilized to evaluate relationships
among cardiorespiratory fitness values, vascular function, and cytokine (IL-6 and TNF-α)
concentration responses following the maximal effort. Subject demographics were
compared using descriptive statistics and independent t-tests. All data are expressed as
mean ± SEM unless otherwise noted. Statistical significance was set at P < 0.05.
Results
Subject Characteristics
Of the twenty-five subjects that volunteered for this study, one individual in the
non-obese group requested to withdraw from the study due to an aversion to the blood
sampling procedures. Therefore, 12 subjects in both the non-obese and obese group were
used in the final analyses. Subject characteristics for both non-obese and obese males are
presented in Table 1. Body mass, BMI, body fat percentage, fat mass, fat-free mass,
resting HR and SBP were significantly (P < 0.05) different between the groups.
Additionally, PRE-E TNF-α concentration was significantly (P = 0.037) elevated in obese
males compared to non-obese males.
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Physiological variables in response to acute maximal exercise
Table 2 provides the physiological variables in response to the maximal exercise
test. The total duration of the maximal exercise test (not including warm-up) was
significantly (P < 0.05) higher in the non-obese males compared to the obese males. One
non-obese male had difficulty breathing through the respiratory gas sensor. The subject
had the flow sensor removed during the maximal exercise test, however the subject
continued with the protocol until expressing volitional fatigue. Therefore, the non-obese
group had 11 subjects for all VO2max data analyses. VO2max expressed per kilogram of
body mass and lean mass was significantly (P < 0.05) greater in non-obese males.
Absolute VO2max was significantly (P < 0.05) greater in obese males. Maximal lactate,
RPE, and HR were similar in both groups. Furthermore, RM ANOVA revealed that SBP
had significant main effects for group (P < 0.001) and time (P < 0.001). A group x time
interaction was not significant for SBP. A one-way ANOVA revealed a significant (P <
0.001) F-ratio for SBP across time for both groups. Furthermore, a Bonferroni post-hoc
analysis revealed that SBP was significantly elevated (P < 0.05) POST-E compared to
PRE-E, before returning to values similar to PRE-E at POST-1, POST-2, POST-24, and
POST-48.
FBF in response to acute maximal exercise
The AUC for PRE-E FBF, at baseline and during RH, for both groups are shown in
Figure 1. As demonstrated in Figure 1, obese males had a significant elevation in FBF
(Obese, 406.0 ± 32.8 ml/100 ml/min·sec vs. Non-obese, 271.4 ± 19.3 ml/100 ml/min·sec; P
= 0.002) and FBF during RH (Obese, 714.8 ± 54.3 ml/100 ml/min·sec vs. Non-obese,
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447.0 ± 51.0 ml/100 ml/min·sec; P = 0.002) at PRE-E measures. RM ANOVA revealed
that FBF, both at baseline and during RH, had significant main effects for group (Baseline
FBF, P = 0.014; RH FBF, P = 0.013) and time (Baseline FBF, P = 0.001; RH FBF, P =
0.001). A group x time interaction was not significant for FBF at baseline or during RH.
A one-way ANOVA revealed a significant (P < 0.001) F-ratio for FBF, at baseline and
during RH, for both groups across time. Furthermore, a Bonferroni post-hoc analysis
revealed that FBF, at baseline and during RH, for both groups was significantly elevated
(P < 0.05) POST-E compared to PRE-E, before returning to values similar to PRE-E at
POST-1, POST-2, POST-24, and POST-48.
VR, expressed as total excess blood flow above baseline, is shown in Figure 2. RM
ANOVA revealed that VR had significant main effects for group (P = 0.033) and time (P =
0.026). A group x time interaction was not significant for VR. A one-way ANOVA
revealed a significant (P = 0.014) F-ratio for VR across time for only non-obese males.
Furthermore, a Bonferroni post-hoc analysis revealed that VR was significantly elevated (P
= 0.017) POST-E compared to PRE-E in non-obese males. VR remained elevated in nonobese males, although not significantly different from PRE-E, at POST-1, POST-2, and
POST-24 before returning to values at POST-48 significantly (P = 0.044) lower than
POST-E. In obese males, a one-way ANOVA revealed that VR was not significantly (P =
0.497) different across time. As demonstrated figure 2, an independent sample t-test
revealed a significantly higher VR PRE-E in obese males compared to non-obese males
(308.8 ± 29.7 ml/100 ml/min·sec vs. 175.5 ± 38.7 ml/100 ml/min·sec, P = 0.012).
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The VR measures across time were significantly correlated to observed SBP across
time (r = 0.359, P < 0.001). Furthermore, VR PRE-E was not significantly correlated to
VO2max per lean muscle mass (r = -0.207, P = 0.343). However, VR PRE-E was
significantly correlated to BMI (r = .475, P = 0.019), fat mass (r = 0.446, P = 0.029), lean
mass (r = 0.527, P = 0.008), and percent fat (r = 0.508, P = 0.011). Figure 3 illustrates the
relation between VR and percent fat.
IL-6 and TNF-α response to acute maximal exercise
One non-obese male did not have a blood sample collected at 1 hour post exercise
and one obese male had an undetectable IL-6 concentration at 24 hours post exercise.
Therefore, the non-obese group had 11 subjects for IL-6 and TNF-α analysis at 1 hour post
exercise and the obese group had 11 subjects for IL-6 analyses at 24 hours post exercise.
Although IL-6 was not significantly different between groups at PRE-E, TNF-α was
significantly (P = 0.037) elevated in obese compared to non-obese males (Table 1). RM
ANOVA revealed that IL-6 had a significant main effect for group (P = 0.032) and time (P
= 0.008). A group x time interaction was not significant with IL-6. A one-way ANOVA
revealed a significant (P = .014) F-ratio for IL-6 across time for only obese males. A
Bonferroni post-hoc analysis did not reveal any differences in IL-6 across time in obese
males. However, a paired-sample T-test between the non-obese and obese male’s peak IL6 (POST-2) and lowest IL-6 (POST-48) revealed a significant reduction (P < 0.05) of
57.63 and 66.82%, respectively.
Additionally, RM ANOVA revealed that TNF-α had a significant main effect for
group (P = 0.017) and time (P = 0.027). A group x time interaction was not significant
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with TNF-α. A one-way ANOVA with TNF-α samples from all males combined revealed
a non-significant (P = 0.786) F-ratio across time. Additionally, when TNF-α was
compared within non-obese and obese males, a one-way ANOVA revealed a nonsignificant F-ratio for non-obese (P = 0.653) and obese males (P = 0.978) across time.
Furthermore, VR, BMI, percent fat, and fat mass were not significantly correlated
to IL-6 or TNF-α. The mean coefficient of variation for all IL-6 and TNF-α samples run
was 16.0 ± 1.3% and 9.9 ± 0.6%, respectively.
Discussion
This is the first study that evaluated FBF and VR in obese males after a single
maximal bout of aerobic exercise. The main finding in this study was that a single
maximal bout of aerobic exercise resulted in an immediate post-exercise significant
increase in VR in non-obese individuals only. Although obese individuals did not
demonstrate a significant increase in VR following a single maximal bout of exercise, the
VR response following exercise was not significantly different between non-obese and
obese males. FBF response to exercise was not significantly different at baseline and
during RH between non-obese and obese males. FBF and FBF during RH significantly
increased in both groups immediately after exercise, before returning to PRE-E levels
within 1 hour of exercise.
Furthermore, the exercise response of IL-6 and TNF-α was not significantly
different in non-obese and obese males. The magnitude of change in IL-6 at POST-48
from POST-2 was greater in obese males. No response was observed in TNF-α for up to
48 hours following a single bout of maximal exercise in non-obese and obese males.
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Similar to previous studies, following an acute aerobic exercise bout, our study
revealed an increase in FBF and VR immediately following exercise (2, 3, 15, 32).
Kingwell and colleagues demonstrated an increase in FBF immediately following 30
minutes of cycling at 65% of VO2max in healthy individuals (15). However, it is unclear
how long the increase in FBF lasted after exercise, as the investigators only showed results
from three subjects who continued to have an increased FBF at 60 minutes post exercise.
FBF and VR have been measured after a maximal exercise test in only two other studies.
Bousquet-Santos and colleagues demonstrated a significant increase in FBF during RH and
VR immediately following a maximal exercise test in healthy sedentary individuals (3).
The increase in FBF during RH and VR were still significantly elevated at 1 hour post
exercise before returning to baseline levels within 2 hours post exercise. Baynard and
colleagues evaluated the difference in FBF during RH in resistance trained versus
endurance trained men following a maximal exercise test (2). Similar to our study, there
were significant differences in VO2max and testing time when comparing the two groups.
FBF during RH was significantly elevated after exercise, although no differences were
shown between the two groups both prior to and following exercise. However, Baynard
and colleagues did not report the FBF after exercise, which would have allowed for
differentiation of improved VR or vascular conductance after exercise (2).
ED has been associated with obesity, as well as the progression of CHF (30, 37).
In a recent study, Umpierre and colleagues evaluated the difference in FBF and FBF
during RH following a sub-maximal cycle test in CHF patients versus healthy controls
(31). There were no significant differences in FBF or FBF during RH between the CHF
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patients and healthy controls prior to exercise (31). FBF following exercise had a similar
temporal response between the two groups. FBF was significantly elevated after the
exercise session and returned to pre-exercise values within 1 hour after exercise. FBF
during RH was significantly elevated in both groups at 30 minutes post-exercise and
significantly different between CHF patients and healthy controls. Although our FBF
during RH response was not significantly different between non-obese and obese males
immediately following exercise, we did not measure FBF at 30 minutes post-exercise in
non-obese and obese males. These findings between CHF patients and healthy controls, in
which a difference in endothelium-dependent vasodilation is expected across groups, were
similar to our findings. In our study, although the magnitude of change in VR was higher
in non-obese males, our obese males presented normal endothelium-dependent
vasodilation following a single maximal aerobic bout of exercise. Additionally, this study
is the first to demonstrate an enhanced vascular conductance in obese males immediately
following a maximal bout of exercise. An increased vascular conductance immediately
after exercise had previously been shown in non-obese healthy individuals (3).
Although IL-6 was not significantly different at baseline between our non-obese
and obese males, TNF-α was significantly elevated in obese males at pre-exercise levels.
While both markers have been shown to be significantly correlated with adiposity levels,
Van Guilder and colleagues suggested that this correlation is only present among obese
individuals who also have the metabolic syndrome (MetS) (24, 26, 33). Although a
mechanism responsible for the difference in obese individuals with and without MetS is
unknown, obese individuals without MetS had similar baseline concentrations of IL-6 and
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TNF-α to that of normal weight individuals (33). In the current study, we did not access
the presence of the MetS in our obese males. However, the similarity in IL-6 and TNF-α
previously reported between normal weight individuals and obese individuals without the
MetS may help explain the current study’s similar temporal response to IL-6 and TNF-α
following exercise in non-obese and obese males. Additionally, it has previously been
reported that IL-6 and TNF-α significantly increase following a maximal bout of exercise
(16). In spite of these earlier findings, IL-6 and TNF-α did not significantly increase
following exercise in our study. However, it is important to note that in both groups, there
was a significant reduction between the highest IL-6 concentration (POST-2) and lowest
IL-6 concentration (POST-48). Although we do not know the origin of secretion for the
IL-6 measured in this study, these results potentially demonstrate an anti-inflammatory
effect of muscle derived IL-6 following maximal exercise. It is important to note that we
did not take a sample of blood between POST and 1 hour after exercise and are unable to
conclude that a shortened response did not occur within our measurement periods.
Furthermore, the IL-6 and TNF-α response to acute exercise led us to believe that FBF and
VR at rest and following a single maximal aerobic bout of exercise are independent of
these blood markers in non-obese and obese males.
These results must be viewed within the context of this study’s limitations. Studies
have demonstrated with an infusion of a NO inhibitor, such as NG-monomethyl-L-arginine
(L-NMMA), that FBF is dependent on NO bioavailability in both sedentary and trained
individuals (13, 15). Shear stress, generated by flow during exercise and RH, is one of the
most important mechanical regulators of endothelial NO synthase (9). Although we did
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not measure shear stress or NO metabolites, we can not discount that a difference in shear
stress may have contributed to the distinct VR magnitude changes observed between nonobese and obese males after exercise. Conversely, we also did not measure the size of the
arteries in the forearm under investigation. Rognmo and colleagues speculated that lower
fitness levels were often associated with smaller arteries that may have a greater vascular
dilation response due to an increased hyperemic shear stress (25). Our non-obese males
had a significantly lower cardiorespiratory fitness level, demonstrated by a lower VO2max
per FFM. The significantly enhanced FBF and FBF during RH in obese males may have
been attributed to a smaller artery size and subsequent enhanced hyperemic shear stress.
This is further illustrated by the significant main effect for SBP between groups, in which
SBP was elevated in obese individuals across all time points. Lastly, there were no FBF
measurements between the end of exercise and 1 hour following exercise. As described
above, changes in FBF following exercise may have occurred within the first hour after
exercise (31).
In conclusion, a single maximal aerobic bout of exercise results in increased FBF,
at baseline and during RH, in non-obese and obese males. Additionally, non-obese males
had a greater magnitude change than obese males in VR immediately following exercise.
These changes in FBF and VR following exercise demonstrate that although non-obese
and obese males have an increased vascular conductance immediately after exercise, only
non-obese males have a significantly enhanced reactive vasodilation following exercise.
TNF-α did not change in response to a single maximal bout of exercise and does not
further explain the changes seen in FBF following the exercise session. Likewise,
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although the response of IL-6 to maximal exercise was not significantly different between
non-obese and obese males, both groups demonstrated a significant reduction in IL-6 at
peak values, 2 hours post-exercise, compared to 48 hours post-exercise. This change could
help explain an anti-inflammatory effect of muscle-derived IL-6. However, the IL-6
response to exercise did not explain the observed response to FBF following the exercise
session. Future studies are warranted that investigate the acute effects of various exercise
intensities and VR measurement times in non-obese and obese individuals.
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Table 1

Subject characteristics

Variable

Non-Obese

Obese

Age (years)

21.6 ± 0.4

23.0 ± 1.0

Weight (kg)

67.8 ± 2.8*

121.3 ± 5.0

BMI (kg/m2)

21.9 ± 0.3*

37.0 ± 1.1

Percent Fat (%)

19.8 ± 1.4*

41.3 ± 1.6

Fat Mass (kg)

13.0 ± 1.2*

48.5 ± 3.5

Lean Mass (kg)

51.9 ± 1.9*

67.9 ± 2.5

Resting HR (bmp)

56.0 ± 2.2*

64.0 ± 2.9

Resting SBP (mm Hg)

119.3 ± 4.2*

134.6 ± 3.2

Resting DBP (mm Hg)

66.6 ± 2.1

73.0 ± 2.7

Baseline IL-6 (pg/mL)

1.4 ± 0.5

1.7 ± 0.5

Baseline TNF-α (pg/mL)

1.3 ± 0.1*

1.7 ± 0.2

* P < 0.05, Non-obese vs. Obese. Values are mean ± SEM.
BMI, Body Mass Index; HR, Heart Rate; SBP, Systolic Blood Pressure; DBP, Diastolic
Blood Pressure; IL, Interleukin; TNF-α, Tumor Necrosis Factor alpha.
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Table 2

Physiological variables in response to acute maximal exercise

Variable

Non-Obese

Obese

Maximal Lactate (mmol/L)

10.6 ± 0.7

9.9 ± 0.7

Maximal RPE

19.5 ± 0.1

19.1 ± 0.2

Maximal HR (bpm)

195.9 ± 2.3

197.0 ± 1.7

Test Duration (s)

709.9 ± 33.6*

545.0 ± 20.7

Relative VO2max (mLO2/kg of BW/min)

50.9 ± 1.1*

34.8 ± 1.2

Relative VO2max (mLO2/kg of LM/min)

66.1 ± 1.2*

61.8 ± 1.6

3.4 ± 0.1*

4.1 ± 0.1

Absolute VO2max (LO2/min)

* P < 0.05, Non-obese vs. Obese. Values are mean ± SEM.
RPE, Rating of Perceived Exertion; HR, Heart Rate; VO2max, Maximal Oxygen
Consumption; BW, Body Weight; LM, Lean Mass.
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Forearm Blood Flow Time
(ml/100 ml/min x sec)
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*
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300
200
100
0
FBF

FBF during RH

Figure 1. PRE-E Forearm blood flow calculated as the area under the curve (mean ±
SEM). *p<0.05 Non-obese vs. Obese
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Vascular Reactivity
(ml/100 ml/min x sec)
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Time

Figure 2. Vascular reactivity, calculated as total RH FBF minus total baseline FBF (mean
± SEM). #p<0.05, PRE-E, Obese vs. Non-obese; *p<0.05, Non-obese, POST-E vs. PREE; †p<0.05, Non-obese, POST-48 vs. POST-E.
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Figure 3. Relation between VR PRE-E and Percent Fat (r = 0.508, P = 0.011).
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APPENDIX A
Expanded Methods
Subjects
Forty male subjects between the ages of 18 and 30 years with body mass index
(BMI) values below 25 kg/m2 (N = 20) and greater than 30 kg/m2 (N = 20) were recruited
for the study through flyers posted on campus and through classroom visits. All classroom
visits were approved by the instructor and/or department chair. Classroom visits lasted
less than 5 minutes and consisted of a research staff member describing the project and
answering any questions posed by potential subjects. Potential subjects were not
encouraged to make their interest in participating known during the classroom visit, but
were given a contact number for the Health and Human Performance Laboratory so that
contact could be made at a later time. Potential subjects were made aware that their
participation was completely voluntary and that the course instructor would not be made
aware of who did or did not participate in the project.
Twenty five male subjects between the ages of 19 and 29 years volunteered to
participate in this study. Subjects were categorized by their BMI into either a non-obese (n
= 13, BMI ≤ 25 kg/m2) or obese (n = 12, BMI ≥ 30 kg/m2) group. Subjects were excluded
from the study if they were smokers, had been diagnosed with diabetes or high blood
pressure, had any form of known cardiovascular disease, or were taking medications that
118

would potentially affect vascular function. Subjects were also excluded if they were
participating in high levels of physical activity as determined by the International Physical
Activity Questionnaire (IPAQ) at the time of the study. The IPAQ is a short (4 questions),
7-day physical activity recall for use with young and middle-aged adults. The types of
activity assessed in the IPAQ short include walking, moderate-intensity and vigorousintensity activities. The amount of activity for each type assessed was given a separate
score that required the summation of the duration (minutes) and frequency (days).
Walking, moderate-intensity, and vigorous-intensity were designated MET values of 3.3,
4.0, and 8.0 respectively. High physical activity consisted of individuals meeting one of 2
criteria: 1.) Vigorous-intensity activity on at least 3 days and accumulating at least 1,500
MET-minutes/week or 2.) 7 or more days of any combination of walking, moderate- or
vigorous-intensity activities accumulating at least 3,000 MET-minutes/week. Subjects
were instructed to refrain from exercise for 3 days prior and alcohol and caffeine for 24
hour prior to the start of the study and during the course of the study. Written informed
consent was obtained from each subject before participation in the study. All procedures
were approved by Virginia Commonwealth University’s Institutional Review Board.
Study Design
Subjects were instructed to report to the Human Performance Laboratory at 6:30
a.m. following an overnight fast. Subjects completed a medical history questionnaire and
physical activity readiness questionnaire (PAR-Q) prior to the start of testing.
Additionally, a physical activity diary was employed to evaluate physical activity outside
of the study protocol. After a 30-min rest period, a 7 ml blood sample was obtained from
119

an anticubital vein. Body composition was assessed with dual-energy x-ray
absorptiometry (DXA; Lunar iDXA, GE Healthcare, Madison, WI). Resting heart rate
(HR), blood pressure (BP), and FBF measures were taken prior (PRE-E) to the maximal
exercise test. Blood samples and subsequent BP and FBF measures were taken
immediately after exercise (POST-E) and 1 (POST-1), 2 (POST-2), 24 (POST-24), and 48
(POST-48) hours after the cessation of exercise. All FBF measures were taken on the right
arm, opposite of all blood sampling. All subjects were asked to remain in the laboratory
until after the 2 hour post-exercise measurements. On days 2 and 3, subjects reported to
the laboratory, following an overnight fast, 30 minutes prior to times corresponding to 24
and 48 hours after the cessation of exercise, respectively. A blood sample, BP, and FBF
were taken following a 30-minute rest period.
Maximal Exercise Protocol
Each subject was fitted with a heart rate monitor and respiratory gas analysis
equipment (VMAX Spectra, Sensormedics Corp., Yorba Linda, CA) before completing a
graded exercise test to exhaustion on a treadmill. Following a 3-minute warm-up period (3
mph at 0% grade), the treadmill speed was increased to elicit 80% of each individual’s agepredicted maximal heart rate within 4 minutes. Thereafter, grade was increased by 2%
every 2 minutes until the subject could no longer maintain the treadmill pace. The
protocol was designed to last 8 – 12 minutes. Heart rate was obtained every minute and
rating of perceived exertion (RPE) was obtained once every exercise stage. Following an
immediate blood pressure measurement, a 1-minute post-exercise capillary blood lactate
sample (Lactate Scout, Sports Resource Group, Inc) was obtained and used as a partial
120

criterion to ensure that the subject gave a maximal effort. Breath-by-breath oxygen
consumption was averaged every 10 seconds and the highest averaged value was identified
as the maximal oxygen consumption (VO2max).
Forearm Blood Flow Measurement
Forearm blood flow (FBF) was assessed using mercury in-rubber strain gauge
plethysmography (MSGP; Model AI6, D.E. Hokanson, Inc., Bellevue, WA). Blood
pressure cuffs were positioned around each subject’s upper right arm and right wrist, and a
mercury-in-rubber strain gauge was placed around the forearm approximately 10 cm distal
to the olecranon process (1). During each trial, the wrist cuff was inflated to a pressure of
240 mmHg prior to each measurement to occlude hand circulation. Baseline FBF was
determined by rapidly inflating the upper cuff to 40 mmHg for 10 seconds to occlude
venous flow during a 20 second cycle. Nine measurements were recorded to determine the
average rate of volume change during venous occlusion (ml/100 ml of forearm tissue
volume/min). Subsequently, the upper arm cuff was inflated to 240 mmHg to induce
forearm ischemia for a period of 5 minutes. After 5 minutes of occlusion, the cuff was
released and FBF, as described above, was determined during a 3-minute period of reactive
hyperemia (RH). Each measurement period was edited one at a time. Area under the
curve (AUC), calculated as a flow-time index, provided values for total FBF both at
baseline and during RH. Flow-time index was calculated as the summation of two
consecutive time periods, divided by 2 and multiplied by the measurement time (20
seconds). Vascular reactivity (VR), indicated by total excess blood flow above baseline,
was calculated as total FBF during RH minus total FBF at baseline.
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Biochemical Analyses
Blood samples for analysis of TNF-α and IL-6 were collected into serum separator
tubes and allowed to clot for 30 minutes before being centrifuged for 15 minutes at 1000 x
g. Serum was immediately aliquoted into microtubes and stored at -80°C until analyzed.
Concentrations of tumor necrosis factor-α and interleukin-6 were determined through
enzyme high-sensitivity immunoassay according to manufacturer’s specifications (R&D
Systems, Minneapolis, MN).
Masks and gloves were worn during the preparation of all assay kits as a
precautionary measure. Distilled water was used to prepare a wash buffer. Specifications
of plate washer were set as follows:
Plate: R&D Systems
Bottom Shape: Flat
Centering: 0.8 mm
Asp. Hor. Pos.: 2.0 mm
Asp. Vert. Pos.: 12.0 mm
Bot. Vert. Pos.: 11.0 mm
B.W. Vert. Pos.: 9.0 mm
Horizontal Speed: 4
Vertical Speed: 4
Asp. Downw. Speed: 0
Disp. Upw. Speed: 2
Bot. Downw. Speed: 6
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Bot. Upward Speed: 9
Shaking Amplitude: 0
Shaking Speed: 0
Kit: R&D Systems
Method 1: Wash
Mode: Plate
Crosw. Asp.: No
Asp. Time: 1.0 s
Volume: 400 μl
Overflow: 3.2 mm
Liquid: Wash W1
Flow: 00
Nr. Of Cycles: 6
Soaking: 30 s
Met. Intervals: 0 m 0 s
Method 2: Asp.
Mode: Plate
Crosw. Asp.: No
Asp. Time: 1.5 s
Nr. Of Cycles: 1
Soaking: 0 m 0 s
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Serum cytokine concentration was determined using a microplate reader (Model
680 XR, Bio-Rad Laboratories, Inc., Hercules, CA). The reading parameters for the
endplate protocol were set 490 nm (measurement filter) and 650 nm (reference filter). All
samples were analyzed in duplicate and the mean concentration of each sample was used
during the statistical analysis.
Statistical Analysis
A mixed between-within repeated measures (RM) ANOVA (SPSS, Chicago, IL:
V16.0) was used to determine the impact of a maximal exercise bout on systolic blood
pressure (SBP), FBF, VR, and serum cytokine (IL-6 and TNF-α) concentration changes
between the two groups (non-obese and obese males) across six different time periods
(PRE-E, POST-E, POST-1, POST-2, POST-24, and POST-48). If a main effect was
observed within groups, a one-way ANOVA was used to determine differences across
time, with a Bonferroni post-hoc analysis being performed to identify differences.
Additionally, Pearson product-moment correlations were utilized to evaluate relationships
among cardiorespiratory fitness values, vascular function, and cytokine (IL-6 and TNF-α)
concentration responses following the maximal effort. Subject demographics were
compared using descriptive statistics and independent t-tests. All data are expressed as
mean ± SEM unless otherwise noted. Statistical significance was set at P < 0.05.
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